{"content":"<li class=\"n-box-item date-title\" data-end=\"1548219599\" data-start=\"1548133200\" data-txt=\"Monday, December 23, 2019\">Tuesday, January 22, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3424911\" data-ts=\"1548197675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424911-bid-target-aphriaplus-5_2-in-u-s-after-canada-halts-shares-for-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bid target Aphria +5.2% in U.S. after Canada halts shares for news</a></h4><ul>   <li>NYSE-listed shares of medical-cannabis firm Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) are <font color=\"green\">up 5.4%</font> after hours even as the shares are halted in Canadian trading.</li>    <li>Canada also halted trading in Green Growth Brands (<a href='https://seekingalpha.com/symbol/GGBXF' title='Green Growth Brands Inc.'>OTCQB:GGBXF</a>), which reportedly planned a <a href=\"https://seekingalpha.com/news/3419465-green-growth-considers-aphria-bid-update\" target=\"_blank\">$2.1B bid for Aphria</a>.</li>    <li>The Toronto exchange halted trading in the stocks for news pending just after today's market close.</li><li>Aphria wrapped the day with a market cap of about $1.67B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424911\" data-linked=\"Bid target Aphria +5.2% in U.S. after Canada halts shares for news\" data-tweet=\"$APHA $APHA $GGBXF - Bid target Aphria +5.2% in U.S. after Canada halts shares for news https://seekingalpha.com/news/3424911-bid-target-aphriaplus-5_2-in-u-s-after-canada-halts-shares-for-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3424911-bid-target-aphriaplus-5_2-in-u-s-after-canada-halts-shares-for-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424904\" data-ts=\"1548196594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424904-ibm-apha-and-cof-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, APHA and COF among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"green\">+8.3%</font>. <a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color=\"green\">+6.9%</font>. <a href='https://seekingalpha.com/symbol/NAVI' title='Navient Corp'>NAVI</a> <font color=\"green\">+6.0%</font>. <a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color=\"green\">+5.9%</font>. <a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"green\">+4.5%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/TSE' title='Trinseo S.A.'>TSE</a> <font color=\"red\">-9.7%</font>. <a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a> <font color=\"red\">-3.6%</font>. <a href='https://seekingalpha.com/symbol/CPLP' title='Capital Product Partners L.P.'>CPLP</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/CVSI' title='CV Sciences, Inc.'>OTCQB:CVSI</a> <font color=\"red\">-2.4%</font>. <a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color=\"red\">-1.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424904\" data-linked=\"IBM, APHA and COF among notable after hour movers\" data-tweet=\"$EHTH $EHTH $IBM - IBM, APHA and COF among notable after hour movers https://seekingalpha.com/news/3424904-ibm-apha-and-cof-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424904-ibm-apha-and-cof-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424898\" data-ts=\"1548195582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBKR\" target=\"_blank\">IBKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424898-interactive-brokersminus-1_1-after-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interactive Brokers -1.1% after Q4 miss</a></h4><ul><li>Interactive Brokers (IEX:<a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a>) <font color=\"red\">falls 1.1%</font> in after-hours trading after<a href=\"https://www.businesswire.com/news/home/20190122005875/en/\" target=\"_blank\"> Q4 EPS on comprehensive income</a> of 56 cents misses consensus estimate of 62 cents; compares with loss per share of 2 cents in the year-ago period.</li><li>Tax reform cut year-ago EPS by 45 cents.</li><li>Q4 net revenue of $492M misses average analyst estimate by $19M; compares with $515M a year ago.</li><li>Q4 pretax profit margin of 63% vs. 71% in the year-ago quarter.</li><li>Electronic brokerage pretax profit margin of the quarter fell to 63% from 65% Y/Y.</li><li>Q4 total daily average revenue trades increased 30% Y/Y to 951K; customer accounts rose 24% to 598K.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424837-interactive-brokers-group-misses-0_06-misses-revenue\" target=\"_blank\">Interactive Brokers Group misses by $0.06, misses on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424898\" data-linked=\"Interactive Brokers -1.1% after Q4 miss\" data-tweet=\"$IBKR - Interactive Brokers -1.1% after Q4 miss https://seekingalpha.com/news/3424898-interactive-brokersminus-1_1-after-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3424898-interactive-brokersminus-1_1-after-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424897\" data-ts=\"1548195576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWST\" target=\"_blank\">CWST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424897-casella-waste-to-launch-3_1m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casella Waste to launch 3.1M-share offering</a></h4><ul><li>Casella Waste Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CWST' title='Casella Waste Systems, Inc.'>CWST</a>) <font color=\"red\">-4.8%</font> after-hours as it announces a planned <a href=\"https://seekingalpha.com/pr/17387819-casella-waste-systems-announces-proposed-public-offering-class-common-stock\" target=\"_blank\">public offering</a> of 3.1M common shares, with an underwriters option to purchase up to an additional 465K shares.</li><li>CWST says it plans to use the proceeds for general corporate purposes, including potential acquisitions or development of new operations or assets with the goal of complementing or expanding its business, working capital and capital spending.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424897\" data-linked=\"Casella Waste to launch 3.1M-share offering\" data-tweet=\"$CWST - Casella Waste to launch 3.1M-share offering https://seekingalpha.com/news/3424897-casella-waste-to-launch-3_1m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424897-casella-waste-to-launch-3_1m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424895\" data-ts=\"1548194950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUOT\" target=\"_blank\">QUOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424895-quotient-tech-preliminary-numbers-fall-short-sharesminus-2_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient Tech preliminary numbers fall short; shares -2.6%</a></h4><ul>   <li>Quotient Technology (NYSE:<a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a>) is <font color=\"red\">2.6% lower</font> after hours following the release of <a href=\"https://seekingalpha.com/pr/17387957-quotient-announces-certain-preliminary-unaudited-fourth-quarter-full-year-2018-financial\" target=\"_blank\">preliminary Q4 results</a> where revenues fell short of company guidance and analyst consensus.</li>    <li>The company said it expects to report revenues of $106.5M-$107.5M; that's below Quotient's Nov. 7 guidance of $115M-$120M and consensus for $117.7M.</li>    <li>Quotient expects a \"portion of the revenue shortfall will flow through our net loss.\"</li>    <li>For the full year, it's expecting revenues of $386.5M-$387.5M, short of Nov. 7 guidance for $395M-$400M and consensus for $397.57M.</li>    <li>\"Promotion revenue in the fourth quarter was impacted by unexpected softness as a number of CPG customers cut their spend significantly in December,\" says CEO Mir Aamir. \"Revenue from media in the fourth quarter, continued to grow significantly year over year but was also impacted by the CPG spending cuts.\"</li>    <li>The company will offer its full earnings report after the close on Feb. 12, with a conference call at 4:30 p.m. ET that day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424895\" data-linked=\"Quotient Tech preliminary numbers fall short; shares -2.6%\" data-tweet=\"$QUOT - Quotient Tech preliminary numbers fall short; shares -2.6% https://seekingalpha.com/news/3424895-quotient-tech-preliminary-numbers-fall-short-sharesminus-2_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3424895-quotient-tech-preliminary-numbers-fall-short-sharesminus-2_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424892\" data-ts=\"1548194723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424892-td-ameritradeplus-1_9-after-fiscal-q1-eps-beats-dime\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TD Ameritrade +1.9% after fiscal Q1 EPS beats by a dime</a></h4><ul><li>TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) <font color=\"green\">gains 1.9% </font>in after-hours trading after<a href=\"https://seekingalpha.com/pr/17387762-td-ameritrade-delivers-pre-tax-margins-50-percent-record-nna\" target=\"_blank\"> fiscal Q1 adjusted EPS </a>of $1.11 beats the consensus estimate by a dime.</li><li>Q1 net revenue of $1.52B increased from $1.40B in Q4 and $1.26B in the year-ago quarter.</li><li>Record of $32B in net new client assets, an annualized growth rate of 10%, and about 928,000 daily average client trades per day. Mobile trading averaged 240,000 trades per day, up more than 50% from last year.</li><li>Q1 operating margin of 52.5% vs. 45.4% in Q4 and 26.7% in Q1 2018.</li><li>Client assets at Q1-end $1.17T, down 10% from $1.30T at Q4-end, and $1.18T in the end of Q1 2018.</li><li><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.amtd.com&amp;esheet=51928861&amp;newsitemid=20190122005818&amp;lan=en-US&amp;anchor=www.amtd.com&amp;index=2&amp;md5=6139f8d71d36e1c6c68e2b24028961b7\" target=\"_blank\">Conference call</a> on Jan. 23 at 8:30AM ET; 866-393-4306.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424811-td-ameritrade-beats-0_10-beats-revenue\" target=\"_blank\">TD Ameritrade beats by $0.10, beats on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424892\" data-linked=\"TD Ameritrade +1.9% after fiscal Q1 EPS beats by a dime\" data-tweet=\"$AMTD - TD Ameritrade +1.9% after fiscal Q1 EPS beats by a dime https://seekingalpha.com/news/3424892-td-ameritradeplus-1_9-after-fiscal-q1-eps-beats-dime?source=tweet\" data-url=\"https://seekingalpha.com/news/3424892-td-ameritradeplus-1_9-after-fiscal-q1-eps-beats-dime\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424886\" data-ts=\"1548194318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYME\" target=\"_blank\">ZYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424886-zymeworks-files-for-250m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zymeworks files for $250M mixed shelf offering</a></h4><ul><li>Zymeworks (NYSE:<a href='https://seekingalpha.com/symbol/ZYME' title='Zymeworks'>ZYME</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1403752/000119312519014025/d657668ds3a.htm\" target=\"_blank\">prospectus </a>for a $250M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424886\" data-linked=\"Zymeworks files for $250M mixed shelf offering\" data-tweet=\"$ZYME - Zymeworks files for $250M mixed shelf offering https://seekingalpha.com/news/3424886-zymeworks-files-for-250m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424886-zymeworks-files-for-250m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424883\" data-ts=\"1548194108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424883-rexahn-down-11-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn down 11% after hours on equity offering</a></h4><ul><li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) is down <font color=\"red\">11%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17387921-rexahn-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">planned public offering</a> of stock and warrants. Prices, volumes and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424883\" data-linked=\"Rexahn down 11% after hours on equity offering\" data-tweet=\"$RNN $REXN - Rexahn down 11% after hours on equity offering https://seekingalpha.com/news/3424883-rexahn-down-11-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424883-rexahn-down-11-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424881\" data-ts=\"1548193996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLPH\" target=\"_blank\">BLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424881-bellerophon-down-7-after-hours-on-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellerophon down 7% after hours on stock offering</a></h4><ul><li>Bellerophon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a>) slips <font color=\"red\">7%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17387926-bellerophon-therapeutics-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424881\" data-linked=\"Bellerophon down 7% after hours on stock offering\" data-tweet=\"$BLPH - Bellerophon down 7% after hours on stock offering https://seekingalpha.com/news/3424881-bellerophon-down-7-after-hours-on-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424881-bellerophon-down-7-after-hours-on-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424876\" data-ts=\"1548193889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424876-ehealty-launches-2m-share-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EHealty launches 2M-share stock offering</a></h4><ul><li>EHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <a href=\"https://seekingalpha.com/pr/17387897-ehealth-inc-announces-commencement-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 2M shares of common stock. Price and terms have yet to be announced. Shares are up <font color=\"green\">9%</font> after hours after it <a href=\"https://seekingalpha.com/news/3424873-ehealth-sees-strong-q4-shares-2-percent-hours\" target=\"_blank\">posted </a>preliminary Q4 adn 2018 results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424876\" data-linked=\"EHealty launches 2M-share stock offering\" data-tweet=\"$EHTH - EHealty launches 2M-share stock offering https://seekingalpha.com/news/3424876-ehealty-launches-2m-share-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424876-ehealty-launches-2m-share-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424873\" data-ts=\"1548193678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424873-ehealth-sees-strong-q4-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EHealth sees strong Q4; shares up 2% after hours</a></h4><ul><li>On a preliminary basis, eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) expects total Q4 revenue of $133.5M - 135.5M versus consensus of $110.6M. Medicare revenue should be $121.0M - 122.0M. Net income should be $24.3M - 27.3M while non-GAAP EBITDA should be $51.7M - 52.7M.</li><li>Revenue for the year should be $250M - 252M compared to consensus of $227.1M. Medicare revenue should be $210M - 211M. Non-GAAP EBITDA should be $33.5M - 34.5M compared to guidance of $21.9M - 26.9M.</li><li>Submitted Medicare applications in Q4 rose 64% and 39% for the year.</li><li>Final results should be released in late February.</li><li><strong>2019 guidance</strong>: revenue: $290M - 310M; Medicare revenue: $256M - 272M; net income: $16.3M - 21.3M; non-GAAP EBITDA: $45M - 50M.</li><li>Shares are up <font color=\"green\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424873\" data-linked=\"EHealth sees strong Q4; shares up 2% after hours\" data-tweet=\"$EHTH - EHealth sees strong Q4; shares up 2% after hours https://seekingalpha.com/news/3424873-ehealth-sees-strong-q4-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3424873-ehealth-sees-strong-q4-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424867\" data-ts=\"1548193117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424867-ptc-therapeutics-readies-200m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC Therapeutics readies $200M stock offering</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) <a href=\"https://seekingalpha.com/pr/17387822-ptc-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">launches </a>a $200M public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424867\" data-linked=\"PTC Therapeutics readies $200M stock offering\" data-tweet=\"$PTCT - PTC Therapeutics readies $200M stock offering https://seekingalpha.com/news/3424867-ptc-therapeutics-readies-200m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424867-ptc-therapeutics-readies-200m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424865\" data-ts=\"1548193032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBNK\" target=\"_blank\">TBNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424865-territorial-bancorp-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Territorial Bancorp beats by $0.02, beats on revenue</a></h4><ul><li>Territorial Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/TBNK' title='Territorial Bancorp Inc'>TBNK</a>): Q4 GAAP EPS of $0.50 <span style=\"color:green\">beats by $0.02</span>.</li><li>Revenue of $15.7M (-0.4% Y/Y) <font color=\"green\">beats by $0.15M</font>.</li><li>Shares <font color=\"green\">+1.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17387898-territorial-bancorp-inc-announces-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424865\" data-linked=\"Territorial Bancorp beats by $0.02, beats on revenue\" data-tweet=\"$TBNK - Territorial Bancorp beats by $0.02, beats on revenue https://seekingalpha.com/news/3424865-territorial-bancorp-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3424865-territorial-bancorp-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424861\" data-ts=\"1548192951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424861-capital-oneminus-4_1-after-massive-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital One -4.1% after massive Q4 miss</a></h4><ul><li>Capital One Financial (NYSE:<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>) <font color=\"red\">drops 4.1% </font>in after-hours trading after<a href=\"https://seekingalpha.com/pr/17387818-capital-one-reports-fourth-quarter-2018-net-income-1_3-billion-2_48-per-share\" target=\"_blank\"> Q4 adjusted EPS </a>of $1.87 falls far short of consensus estimate of $2.39.</li><li>Q4 net interest income of $5.82B rose 1% Q/Q, flat Y/Y; net interest margin of 6.96% vs. 8.43% in Q3 and 7.03% in Q4 2017.</li><li>Period-end loans held for investment rose 3% during the quarter to $245.9B, with credit-card period-end loans up to $116.4B; consumer banking period-end loans decreased less than 1% to $59.2B; commercial banking period-end loans increased 2% to $70.3B.</li><li>Period-end total deposits increased 1% Q/Q to $249.8B.</li><li>Return on average common equity 10.05% vs. 12.40% in Q3 and negative 8.14% in the year-ago period.</li><li>Tangible book value per share of $69.20 at Q4-end vs. $66.15 at Q3-end.</li><li>C<a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2352092-1&amp;h=1632053463&amp;u=http%3A%2F%2Fwww.capitalone.com%2F&amp;a=www.capitalone.com\" target=\"_blank\">onference call</a> at 5:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424819-capital-one-financial-misses-0_52-misses-revenue\" target=\"_blank\">Capital One Financial misses by $0.52, misses on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424861\" data-linked=\"Capital One -4.1% after massive Q4 miss\" data-tweet=\"$COF - Capital One -4.1% after massive Q4 miss https://seekingalpha.com/news/3424861-capital-oneminus-4_1-after-massive-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3424861-capital-oneminus-4_1-after-massive-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424846\" data-ts=\"1548192328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVCO\" target=\"_blank\">AVCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424846-avalon-globocare-down-9-after-hours-following-124-spike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avalon Globocare down 9% after hours following 124% spike</a></h4><ul><li>Ultra-thinly traded Avalon Globocare (<a href='https://seekingalpha.com/symbol/AVCO' title='Avalon GloboCare Corp.'>OTCQB:AVCO</a>) is down <font color=\"red\">9%</font> after hours following a sharp <font color=\"green\">124%</font> spike on a whopping 322x surge in volume in today's session.</li><li>No particular news accounts for action although it <a href=\"https://seekingalpha.com/news/3423235-avalon-globocare-files-50m-mixed-shelf-offering\" target=\"_blank\">filed </a>a preliminary prospectus last week for a $50M mixed shelf offering.</li><li>CEO David Jin will be speaking at the World Stem Cell Summit in Miami on Thursday.</li><li>The company says it <a href=\"http://www.avalon-globocare.com/aboutus.html#CORPORATEOVERVIEW\" target=\"_blank\">provides </a>strategic advisory and outsourcing services. A subsidiary is focused on the acquisition and management of healthcare facilities while another subsidiary is involved in liquid biopsy, precision medicine (cell therapies) and regenerative medicine.</li><li>At the end of September 2018, it had $3.8M in cash while operations consumed $3.5M during the first three quarters of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424846\" data-linked=\"Avalon Globocare down 9% after hours following 124% spike\" data-tweet=\"$AVCO - Avalon Globocare down 9% after hours following 124% spike https://seekingalpha.com/news/3424846-avalon-globocare-down-9-after-hours-following-124-spike?source=tweet\" data-url=\"https://seekingalpha.com/news/3424846-avalon-globocare-down-9-after-hours-following-124-spike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424840\" data-ts=\"1548192087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424840-ibmplus-5-on-q4-beats-upside-eps-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM +5% on Q4 beats, upside EPS guide</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"green\">gains 4.7%</font> after reporting Q4 results that beat EPS and revenue estimates with revenue down 3.5% Y/Y. Last year, the company broke a nearly six-year streak of declining revenue, which lasted three quarters before dropping again in the September quarter. Analysts had expected Q4 to continue the trend.</li><li>FY19 guidance has EPS of at least $13.90 (consensus: $13.81) with FCF of approximately $12B. The Red Hat acquisition is expected to close in 2H19 and the full-year guide will provide more clarity on last month's sale of certain software products to HCL Technologies.</li><li>Revenue breakdown: Cognitive Solutions, $5.46B (+2% Y/Y in constant currency); Global Business Services, $4.32B (+6% Y/Y); Technology Services &amp; Cloud Platforms, $8.93B (flat Y/Y,); Systems, $2.62B (-20% Y/Y partly on IBM Z cycle dynamics); Global Financing, $402M (-9% Y/Y).</li><li>Strategic imperatives (cloud, data analysis, etc.) revenue was $39.8B for the year, up 9% Y/Y.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://www.ibm.com/investor/events/earnings/4q18.html\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17387820-ibm-reports-2018-fourth-quarter-full-year-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3424816-international-business-machines-beats-0_05-beats-revenue\" target=\"_blank\">International Business Machines beats by $0.05, beats on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424840\" data-linked=\"IBM +5% on Q4 beats, upside EPS guide\" data-tweet=\"$IBM - IBM +5% on Q4 beats, upside EPS guide https://seekingalpha.com/news/3424840-ibmplus-5-on-q4-beats-upside-eps-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3424840-ibmplus-5-on-q4-beats-upside-eps-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424824\" data-ts=\"1548191519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URGN\" target=\"_blank\">URGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424824-urogen-launches-150m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UroGen launches $150M stock offering</a></h4><ul><li>UroGen Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/URGN' title='UroGen Pharma'>URGN</a>) <a href=\"https://seekingalpha.com/pr/17387764-urogen-pharma-announces-proposed-public-offering-ordinary-shares\" target=\"_blank\">initiates </a>a $150M public offering of ordinary shares. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424824\" data-linked=\"UroGen launches $150M stock offering\" data-tweet=\"$URGN - UroGen launches $150M stock offering https://seekingalpha.com/news/3424824-urogen-launches-150m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3424824-urogen-launches-150m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424822\" data-ts=\"1548191427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SELB\" target=\"_blank\">SELB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424822-selecta-bio-readies-stock-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selecta Bio readies stock offering; shares down 13% after hours</a></h4><ul><li>Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences'>SELB</a>) is down <font color=\"red\">13%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17387773-selecta-biosciences-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned stock offering</a>. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424822\" data-linked=\"Selecta Bio readies stock offering; shares down 13% after hours\" data-tweet=\"$SELB - Selecta Bio readies stock offering; shares down 13% after hours https://seekingalpha.com/news/3424822-selecta-bio-readies-stock-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3424822-selecta-bio-readies-stock-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424816\" data-ts=\"1548191335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424816-international-business-machines-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Business Machines beats by $0.05, beats on revenue</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>): Q4 Non-GAAP EPS of $4.87 beats by $0.05; GAAP EPS of $2.15.</li><li>Revenue of $21.76B (-3.5% Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+3.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17387820-ibm-reports-2018-fourth-quarter-full-year-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424816\" data-linked=\"International Business Machines beats by $0.05, beats on revenue\" data-tweet=\"$IBM - International Business Machines beats by $0.05, beats on revenue https://seekingalpha.com/news/3424816-international-business-machines-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3424816-international-business-machines-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424812\" data-ts=\"1548190526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KL\" target=\"_blank\">KL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424812-kirkland-gold-spikes-5-canaccord-starts-coverage-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kirkland Gold spikes 5% as Canaccord starts coverage with a Buy</a></h4><ul><li>Kirkland Gold (<a href='https://seekingalpha.com/symbol/KL' title='Kirkland Lake Gold Ltd.'>KL</a> <font color='green'>+4.9%</font>) rises to all-time highs after Canaccord Genuity initiates coverage with a Buy rating and C$44 price target, citing the miner's balance sheet and its robust free cash flow profile, which suggests further room to increase the dividend and/or accelerate stock buybacks.</li><li>Canaccord highlights KL's Fosterville and Macassa mines as among the highest-grade mines in the world, with reserve grades of 23 g/ton and 21 g/ton, respectively; as such, KL's estimated all-in sustaining costs of $515/oz. for 2020 is the lowest among the seniors and the 44% free cash margin is the highest, the firm says.</li><li>The firm also believes KL offers low geopolitical, development, technical and financing risk.</li><li>Source: Briefing.com</li></ul><div class=\"tiny-share-widget\" data-id=\"3424812\" data-linked=\"Kirkland Gold spikes 5% as Canaccord starts coverage with a Buy\" data-tweet=\"$KL - Kirkland Gold spikes 5% as Canaccord starts coverage with a Buy https://seekingalpha.com/news/3424812-kirkland-gold-spikes-5-canaccord-starts-coverage-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3424812-kirkland-gold-spikes-5-canaccord-starts-coverage-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424936\" data-ts=\"1548189272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDS.A\" target=\"_blank\">RDS.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424936-royal-dutch-shell-cut-to-underweight-morgan-stanley-on-capex-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Dutch Shell cut to Underweight at Morgan Stanley on capex concerns</a></h4><ul><li>Royal Dutch Shell (<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='red'>-2.4%</font>) is lower after Morgan Stanley <a href=\"https://www.proactiveinvestors.co.uk/companies/news/213064/royal-dutch-shell-weak-as-morgan-stanley-downgrades-to-underweight-on-capex-concerns-213064.html\" target=\"_blank\">downgrades</a> shares to Underweight from Equal Weight,saying Shell\u2019s planned share buybacks, dividends and debt reduction would  require $66B in cash to the end of 2020 and leave little room for capex to increase.</li><li>Stanley says Shell\u2019s capex-to-dividend ratio already is unusually low, by far the lowest in the sector and at a  20-year low in the company\u2019s history.</li><li>The firm also says Shell's reserve life is falling much faster than its peers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424936\" data-linked=\"Royal Dutch Shell cut to Underweight at Morgan Stanley on capex concerns\" data-tweet=\"$RDS.A $RDS.B - Royal Dutch Shell cut to Underweight at Morgan Stanley on capex concerns https://seekingalpha.com/news/3424936-royal-dutch-shell-cut-to-underweight-morgan-stanley-on-capex-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3424936-royal-dutch-shell-cut-to-underweight-morgan-stanley-on-capex-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424759\" data-ts=\"1548187267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKCO\" target=\"_blank\">LKCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424759-wb-rdfn-and-attu-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WB, RDFN and ATTU among tech movers</a></h4><ul><li><strong>Gainers: </strong>Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Tech Shs Sponsored American Depositary Receipt Repr 1 Sh'>LKCO</a>) <font color=\"green\">+114%</font>. Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a>) <font color=\"green\">+50%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"green\">+14%</font>. Ability (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a>) <font color=\"green\">+11%</font>. Remark Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) <font color=\"green\">+7%</font>.</li> <li><strong>Losers: </strong>Attunity (NASDAQ:<a href='https://seekingalpha.com/symbol/ATTU' title='Attunity Ltd'>ATTU</a>) <font color=\"red\">-15%</font>. Gravity (NASDAQ:<a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a>) <font color=\"red\">-14%</font>. Weibo Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/WB' title='Weibo Corporation'>WB</a>) <font color=\"red\">-13%</font>. Redfin Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/RDFN' title='Redfin'>RDFN</a>) <font color=\"red\">-11%</font>. Telecom Italia S.p.A. (NYSE:<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424759\" data-linked=\"WB, RDFN and ATTU among tech movers\" data-tweet=\"$LKCO $LKCO $BOXL - WB, RDFN and ATTU among tech movers https://seekingalpha.com/news/3424759-wb-rdfn-and-attu-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424759-wb-rdfn-and-attu-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424923\" data-ts=\"1548186730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEGEF\" target=\"_blank\">MEGEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424923-meg-energy-outlines-big-2019-spending-cut-board-shakeup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MEG Energy outlines big 2019 spending cut, board shakeup</a></h4><ul><li>MEG Energy (<a href='https://seekingalpha.com/symbol/MEGEF' title='Meg Energy Corp.'>OTCPK:MEGEF</a> <font color='red'>-7.6%</font>) says it will <a href=\"https://finance.yahoo.com/news/meg-eyes-spending-cut-board-161003997.html\" target=\"_blank\">slash its capital spending in half</a> to a maximum C$275M (US$206M) this year and review the makeup of its board, after forecasting a 2019 capital plan of C$500M last October.</li><li>In the aftermath of rival Canadian producer Husky Energy's <a href=\"https://seekingalpha.com/news/3423778-husky-drops-bid-meg-energy-lack-strong-shareholder-support\" target=\"_blank\">abandoned C$2.75B offer</a> for the company, MEG says it will focus on increasing cash flow, trimming debt and eventually expanding production.</li><li>MEG says Alberta\u2019s mandated production cuts will limit its 2019 output to 90K-92K bbl/day of oil, while maintaining a target of raising output to 113K bbl/day in 2020.</li><li>While today's announcement does not mention Husky\u2019s failed bid, MEG says it is beginning a \u201cboard renewal process\u201d to ensure it has the necessary leadership \u201cto steward the ultimate potential of the company going forward.\u201d</li><li>Investors should be encouraged that MEG's plan still advances the company's expansion efforts while being funded out of operating cash flow, says Raymond James analyst Chris Cox.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424923\" data-linked=\"MEG Energy outlines big 2019 spending cut, board shakeup\" data-tweet=\"$MEGEF - MEG Energy outlines big 2019 spending cut, board shakeup https://seekingalpha.com/news/3424923-meg-energy-outlines-big-2019-spending-cut-board-shakeup?source=tweet\" data-url=\"https://seekingalpha.com/news/3424923-meg-energy-outlines-big-2019-spending-cut-board-shakeup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424750\" data-ts=\"1548186558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424750-bluemountain-continues-campaign-against-pg-and-e-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlueMountain continues campaign against PG&amp;E bankruptcy</a></h4><ul><li>\"There is no imminent financial pressure,\" and thus no need for a \"hasty and heedless filing,\" says BlueMountain Capital Management in a second letter to PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+7.5%</font>) challenging bankruptcy plans.</li><li>PG&amp;E currently plans to file in a week. BlueMountain is an owner of 11M shares.</li><li>The fund notes that the bankruptcy is likely to enrich PG&amp;E's advisors as well as senior executives, but leave the company's customers stuck with higher costs.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424651-pg-and-e-obtains-5_5b-debtor-possession-financing-shares-plus-8-percent\" target=\"_blank\">PG&amp;E obtains $5.5B in debtor-in-possession financing; shares +8%</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424750\" data-linked=\"BlueMountain continues campaign against PG&amp;E bankruptcy\" data-tweet=\"$PCG - BlueMountain continues campaign against PG&amp;E bankruptcy https://seekingalpha.com/news/3424750-bluemountain-continues-campaign-against-pg-and-e-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3424750-bluemountain-continues-campaign-against-pg-and-e-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424747\" data-ts=\"1548185741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424747-twitter-unveiling-new-features-on-website\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter unveiling new features on website</a></h4><ul>   <li>Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"red\">-3.4%</font>) says it's rolled out its <a href=\"https://twitter.com/Twitter/status/1087791357756956680\" target=\"_blank\">new homepage experience</a> to some users on Twitter.com.</li>    <li>The update adds new features like bookmarks and \"Explore\" along with improved trends and Direct Messages, the company says. Its tweet also highlights an emoji button and advanced search.</li>    <li>\"And coming soon, you'll have easy access to switch between top and latest Tweets, account switching, and so much more,\" Twitter says.</li>    <li>Confusion among users about whether their tweets were coming in chronological or algorithmic order has been a particular criticism among users in the past year, a complaint that the company seems to be addressing with easy switching.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424747\" data-linked=\"Twitter unveiling new features on website\" data-tweet=\"$TWTR - Twitter unveiling new features on website https://seekingalpha.com/news/3424747-twitter-unveiling-new-features-on-website?source=tweet\" data-url=\"https://seekingalpha.com/news/3424747-twitter-unveiling-new-features-on-website\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424916\" data-ts=\"1548184990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424916-u-s-steel-downgraded-to-hold-from-buy-jefferies-on-guidance-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel downgraded to Hold from Buy at Jefferies on guidance risk</a></h4><ul><li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-2.9%</font>) is lower after Jefferies <a href=\"https://thefly.com/thestreet/realmoney/index.php/X%3bNUE%3bCMC%3bSTLD%3bRS%3bCLFid2851571/X%3bNUE%3bCMC%3bSTLD%3bRS%3bCLF-Jefferies-downgrades-US-Steel-to-Hold-on-guidance-risk\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $24 price target, cut from $38, saying disappointing Q4 earnings and Q1 guidance will begin to reflect the extent of recent steel margin weakness.</li><li>While remaining constructive on the broader steel sector, drivers for a meaningful recovery at U.S. Steel are \"hard to identify\" and the company's 2019 EBITDA guidance risks missing expectations, Jefferies analyst Seth Rosenfeld writes.</li><li>Among U.S.-based steel names, the firm has more regard for Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>), Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>), Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>), Reliance Steel (NYSE:<a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a>) and Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3424916\" data-linked=\"U.S. Steel downgraded to Hold from Buy at Jefferies on guidance risk\" data-tweet=\"$X $X $NUE - U.S. Steel downgraded to Hold from Buy at Jefferies on guidance risk https://seekingalpha.com/news/3424916-u-s-steel-downgraded-to-hold-from-buy-jefferies-on-guidance-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3424916-u-s-steel-downgraded-to-hold-from-buy-jefferies-on-guidance-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424746\" data-ts=\"1548184764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424746-barrington-sees-15-share-for-usa-tech-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrington sees $15/share for USA Tech sale</a></h4><ul><li>Barrington Research thinks a sale is the best option for USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) shareholders and values the potential sale at $10 to $15 per share.</li><li>The firm says USAT's position as a unique asset in the unattended retail market is offset by \"the credibility gap\" following the internal investigation and rebuilding of the senior exec team.</li><li>Source: Briefing.com.</li><li>USAT shares are <font color=\"green\">up 0.8%</font> to $5.76.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424746\" data-linked=\"Barrington sees $15/share for USA Tech sale\" data-tweet=\"$USAT - Barrington sees $15/share for USA Tech sale https://seekingalpha.com/news/3424746-barrington-sees-15-share-for-usa-tech-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3424746-barrington-sees-15-share-for-usa-tech-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424745\" data-ts=\"1548184762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424745-sony-moving-europe-hq-to-amsterdam-brexit-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony moving Europe HQ to Amsterdam as Brexit plan</a></h4><ul>   <li>Sony (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color=\"red\">-3.3%</font>) is the latest large company planning Brexit contingencies, as it <a href=\"https://asia.nikkei.com/Business/Companies/Sony-moves-European-base-to-Holland-as-Brexit-nears\" target=\"_blank\">moves its European headquarters</a> to the Netherlands from the UK, Nikkei reports.</li>    <li>It will do that by merging England-based Sony Europe into a new entity in Amsterdam; the England unit will continue to manage product imports and sales and no personnel will be relocated.</li>    <li>Meanwhile, the merged entity will start operations in April, with Britain's exit from the EU set for the end of March. That should allow Sony to ensure supply stability by continuing to take advantage of the existing customs regime.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424745\" data-linked=\"Sony moving Europe HQ to Amsterdam as Brexit plan\" data-tweet=\"$SNE - Sony moving Europe HQ to Amsterdam as Brexit plan https://seekingalpha.com/news/3424745-sony-moving-europe-hq-to-amsterdam-brexit-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3424745-sony-moving-europe-hq-to-amsterdam-brexit-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424743\" data-ts=\"1548184367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424743-is-bottom-in-for-hal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Is bottom in for HAL?</a></h4><ul><li>Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-3.2%</font>) is helping the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-1.8%</font>) to a rough day after a Q4 earnings beat, but comments about the Q1 outlook suggested a weaker-than-hoped quarter.</li><li>According to Stifel's Stephen Gengaro's calculations, HAL's guidance suggests EPS of around $0.22-$0.24 vs. consensus of $0.31.</li><li>Cowen bull Marc Bianchi, meanwhile, isn't sure Q1 will mark the bottom for HAL earnings, noting continued price pressure.</li><li>National Bank Financial says HAL's outlook reinforces its caution on Canadian frackers, and trims its estimate for STEP Energy Services (<a href='https://seekingalpha.com/symbol/SNVFF' title='Sonoro Energy Ltd.'>OTC:SNVFF</a>).</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424540-halliburton-minus-1-percent-north-american-activity-slows\" target=\"_blank\">Halliburton -1% as North American activity slows</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424743\" data-linked=\"Is bottom in for HAL?\" data-tweet=\"$HAL $HAL $XLE - Is bottom in for HAL? https://seekingalpha.com/news/3424743-is-bottom-in-for-hal?source=tweet\" data-url=\"https://seekingalpha.com/news/3424743-is-bottom-in-for-hal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424740\" data-ts=\"1548183658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEIX\" target=\"_blank\">PEIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424740-pacific-ethanol-and-flexible-solutions-international-among-energy-materials-gainers-arconic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Ethanol and Flexible Solutions International among Energy/Materials gainers; Arconic among losers</a></h4><ul><li><b>Gainers: </b>Pacific Ethanol (NASDAQ:<a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a>) <font color=\"green\">+11%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+11%</font>. Flexible Solutions International (NYSEMKT:<a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Seadrill Partners (NYSE:<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a>) <font color=\"red\">-21%</font>. Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>) <font color=\"red\">-17%</font>. Crescent Point Energy (NYSE:<a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp'>CPG</a>) <font color=\"red\">-13%</font>. Permianville Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/PVL' title='Enduro Royalty Shs of Benef Interest'>PVL</a>) <font color=\"red\">-11%</font>. Profire Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424740\" data-linked=\"Pacific Ethanol and Flexible Solutions International among Energy/Materials gainers; Arconic among losers\" data-tweet=\"$PEIX $PEIX $LEU - Pacific Ethanol and Flexible Solutions International among Energy/Materials gainers; Arconic among losers https://seekingalpha.com/news/3424740-pacific-ethanol-and-flexible-solutions-international-among-energy-materials-gainers-arconic?source=tweet\" data-url=\"https://seekingalpha.com/news/3424740-pacific-ethanol-and-flexible-solutions-international-among-energy-materials-gainers-arconic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424733\" data-ts=\"1548182100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424733-editas-and-crispr-weigh-on-biotechs-xbi-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Editas and CRISPR weigh on biotechs, XBI down 3%</a></h4><ul><li>The broad market's down day notwithstanding, biotechs are getting drubbed, led by <a href=\"https://seekingalpha.com/news/3424636-editas-ceo-bids-adieu-shares-18-percent\" target=\"_blank\">Editas Medicine</a> and <a href=\"https://seekingalpha.com/news/3424548-citi-cuts-crispr-therapeutics-sell-shares-7-percent-premarket\" target=\"_blank\">CRISPR Therapeutics</a>. The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color=\"red\">-2.9%</font>) is down, albeit on average volume.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"red\">-1.5%</font>)(<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color=\"red\">-2.3%</font>)(<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color=\"red\">-2.4%</font>)(<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"red\">-1.5%</font>)(<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color=\"red\">-2.1%</font>)(<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color=\"red\">-2.9%</font>)(<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-3.6%</font>)(<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color=\"red\">-3.4%</font>)(<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines'>BPMC</a> <font color=\"red\">-2.8%</font>)(<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"red\">-2%</font>)(<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color=\"red\">-2.6%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-1.5%</font>)(<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color=\"red\">-0.8%</font>)(<a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color=\"red\">-3.6%</font>)(<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color=\"red\">-3.2%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"red\">-3.8%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"red\">-0.6%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-0.8%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-0.2%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-0.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424733\" data-linked=\"Editas and CRISPR weigh on biotechs, XBI down 3%\" data-tweet=\"$IONS $XBI $IONS - Editas and CRISPR weigh on biotechs, XBI down 3% https://seekingalpha.com/news/3424733-editas-and-crispr-weigh-on-biotechs-xbi-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3424733-editas-and-crispr-weigh-on-biotechs-xbi-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424730\" data-ts=\"1548181417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424730-u-s-rejects-chinas-offer-of-prep-trade-talks-ft-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. rejects China&#39;s offer of prep trade talks: FT (update)</a></h4><ul><li>The Trump administrations<a href=\"https://www.ft.com/content/466cc9e2-1e4c-11e9-b126-46fc3ad87c65\" target=\"_blank\"> turned down</a> an offer by two Chinese vice-ministers to hold preparatory trade talks because the two sides haven't progressed on two important issues, the <em>Financial Times</em> reports.</li><li>This week's trip by Wang Shouwen and Liao Min was intended to prepare for a higher-level meeting in Washington on Jan. 30-31 by China Vice-Premier Liu He and U.S. Trade Rep Robert Lighthizer.</li><li><strong>Update at 6:05 PM ET</strong>: White House economic adviser Larry Kudlow told CNBC that no intermediate meeting had been scheduled other than the visit by Liu next week.</li><li>Major U.S. stock averages extend their declines, with the S&amp;P <font color=\"red\">sliding 1.8%</font>, Nasdaq <font color=\"red\">-2.1%</font>, and Dow <font color=\"red\">-1.7%</font>.</li><li>U.S. cites lack of progress on \"forced\" technology transfers and \"structural\" reforms to China's economy, FT reports, citing people briefed on the negotiations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424730\" data-linked=\"U.S. rejects China&#39;s offer of prep trade talks: FT (update)\" data-tweet=\"U.S. rejects China&#39;s offer of prep trade talks: FT (update) https://seekingalpha.com/news/3424730-u-s-rejects-chinas-offer-of-prep-trade-talks-ft-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3424730-u-s-rejects-chinas-offer-of-prep-trade-talks-ft-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424725\" data-ts=\"1548180134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONB\" target=\"_blank\">ONB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424725-old-national-bancorpminus-5_0-q4-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Old National Bancorp -5.0% as Q4 disappoints</a></h4><ul><li>Old National Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/ONB' title='Old National Bancorp'>ONB</a>) <font color=\"red\">slides 5.0%</font> after <a href=\"https://seekingalpha.com/pr/17386409-old-national-reports-4th-quarter-net-income-47_5-million-0_28-earnings-per-share\" target=\"_blank\">Q4 adjusted EPS</a> of 32 cents misses consensus estimate by 4 cents.</li><li>Q4 net interest income on fully taxable equivalent basis of $146.2M compares with $130.8M in Q3; net interest margin (FTE) increased to 3.64% from 3.51% in Q4.</li><li>Excluding notable items, adjusted noninterest expense in Q4 was $126.9M vs. $108.4M in Q3.</li><li>Q4 adjusted efficiency ratio of 63.31% compares with 58.67% in Q3 and 63.58% in the year-ago quarter.</li><li>Total loans increased $1.1B with the Klein partnership adding $1.0B; deposits rose $1.7B--Klein partnership added $1.7B and Wisconsin branch sale subtracted $230.6M.</li><li><strong><a href=\"https://seekingalpha.com/article/4234641-old-national-bancorp-2018-q4-results-earnings-call-slides\" target=\"_blank\">For 2019</a></strong>, ONB sees strong commercial loan production continuing and FTE NIM, excluding accretion income, benefiting from low-cost deposits and improving asset yield; yield-curve \"remains challenging.\"</li><li>Sees majority of cost savings from Klein transaction in H2 2019.</li><li>Sees 2019 tax rate at ~24% FTE and ~21% GAAP.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424503-old-national-bancorp-misses-0_04-beats-revenue\" target=\"_blank\">Old National Bancorp misses by $0.04, beats on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424725\" data-linked=\"Old National Bancorp -5.0% as Q4 disappoints\" data-tweet=\"$ONB - Old National Bancorp -5.0% as Q4 disappoints https://seekingalpha.com/news/3424725-old-national-bancorpminus-5_0-q4-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3424725-old-national-bancorpminus-5_0-q4-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424718\" data-ts=\"1548179791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBWM\" target=\"_blank\">MBWM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424718-mercantile-bank-leads-financial-gainers-lm-funding-america-and-goosehead-insurance-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercantile Bank leads financial gainers; LM Funding America and Goosehead Insurance among losers</a></h4><ul><li><b>Gainers: </b>Mercantile Bank (NASDAQ:<a href='https://seekingalpha.com/symbol/MBWM' title='Mercantile Bank Corporation'>MBWM</a>) <font color=\"green\">+7%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a>) <font color=\"green\">+7%</font>. Flagstar Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/FBC' title='Flagstar Bancorp, Inc.'>FBC</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-21%</font>. China Commercial Credit (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"red\">-11%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"red\">-11%</font>. Goosehead Insurance (NASDAQ:<a href='https://seekingalpha.com/symbol/GSHD' title='Goosehead Insurance'>GSHD</a>) <font color=\"red\">-8%</font>. Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings'>RLGY</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424718\" data-linked=\"Mercantile Bank leads financial gainers; LM Funding America and Goosehead Insurance among losers\" data-tweet=\"$MBWM $MBWM $WHLR - Mercantile Bank leads financial gainers; LM Funding America and Goosehead Insurance among losers https://seekingalpha.com/news/3424718-mercantile-bank-leads-financial-gainers-lm-funding-america-and-goosehead-insurance-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3424718-mercantile-bank-leads-financial-gainers-lm-funding-america-and-goosehead-insurance-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424717\" data-ts=\"1548179492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKCO\" target=\"_blank\">LKCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424717-arnc-rnn-edit-and-sdlp-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARNC, RNN, EDIT and SDLP among notable midday movers</a></h4><ul><li><strong>Gainers:</strong> Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Tech Shs Sponsored American Depositary Receipt Repr 1 Sh'>LKCO</a>) <font color=\"green\">+136%</font>. UQM Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a>) <font color=\"green\">+46%</font>. Staffing 360 Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a>) <font color=\"green\">+24%</font>. MYnd Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a>) <font color=\"green\">+18%</font>. Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a>) <font color=\"green\">+15%</font>.  XTL Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a>) <font color=\"green\">+14%</font>. MediWound (NASDAQ:<a href='https://seekingalpha.com/symbol/MDWD' title='Mediwound Ltd.'>MDWD</a>) <font color=\"green\">+13%</font>. Liquidia Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/LQDA' title='Liquidia Technologies'>LQDA</a>) <font color=\"green\">+14%</font>. Pacific Ethanol (NASDAQ:<a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a>) <font color=\"green\">+13%</font>. Compugen (NASDAQ:<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>Insignia Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ISIG' title='Insignia Systems, Inc.'>ISIG</a>) <font color=\"red\">-23%</font>. Editas Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>) <font color=\"red\">-21%</font>. Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-21%</font>. Seadrill Partners (NYSE:<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a>) <font color=\"red\">-19%</font>. Oasmia Pharmaceutical AB (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a>) <font color=\"red\">-17%</font>. Attunity (NASDAQ:<a href='https://seekingalpha.com/symbol/ATTU' title='Attunity Ltd'>ATTU</a>) <font color=\"red\">-17%</font>. Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"red\">-16%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a>) <font color=\"red\">-16%</font>. Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>) <font color=\"red\">-16%</font>. Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424717\" data-linked=\"ARNC, RNN, EDIT and SDLP among notable midday movers\" data-tweet=\"$LKCO $LKCO $UQM - ARNC, RNN, EDIT and SDLP among notable midday movers https://seekingalpha.com/news/3424717-arnc-rnn-edit-and-sdlp-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424717-arnc-rnn-edit-and-sdlp-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424716\" data-ts=\"1548179032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424716-equinor-halts-drilling-arctic-exploration-well-after-incident\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinor halts drilling Arctic exploration well after incident</a></h4><ul><li>Equinor (<a href='https://seekingalpha.com/symbol/EQNR' title='Equinor ASA'>EQNR</a> <font color='red'>-2.4%</font>) <a href=\"https://www.reuters.com/article/equinor-exploration-incident/update-1-equinor-stops-drilling-at-arctic-well-after-incident-idUSL8N1ZL3J8\" target=\"_blank\">stops drilling a key exploration well</a> in the Barents Sea following a well incident last week.</li><li>A package on a blowout preventer was unintentionally disconnected when Seadrill's (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-7.3%</font>) <em>West Hercules</em> rig was drilling the Gjoekaasen well offshore Norway, and  work had to be halted, Norway\u2019s petroleum watchdog agency  reports; no personal injuries or environmental harm occurred during the incident.</li><li>The \u201chigh-risk, high-impact\u201d well could hold as many as 1.4B boe, says Aker BP, one of EQNR\u2019s partners.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424716\" data-linked=\"Equinor halts drilling Arctic exploration well after incident\" data-tweet=\"$EQNR $EQNR $SDRL - Equinor halts drilling Arctic exploration well after incident https://seekingalpha.com/news/3424716-equinor-halts-drilling-arctic-exploration-well-after-incident?source=tweet\" data-url=\"https://seekingalpha.com/news/3424716-equinor-halts-drilling-arctic-exploration-well-after-incident\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424711\" data-ts=\"1548178152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424711-lipocine-completes-round-trip-from-lpcn-1144-stoked-spike-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine completes round trip from LPCN 1144-stoked spike; shares down 7%</a></h4><ul><li>Profit-takers have obliterated the brief rally in Lipocine (<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color=\"red\">-6.6%</font>). Shares jumped as high as $2.64 (<font color=\"green\">+66%</font>) last Thursday after the company <a href=\"https://seekingalpha.com/news/3423788-lipocines-lpcn-1144-shows-positive-action-liver-fat-study-shares-125-percent-premarket\" target=\"_blank\">announced </a>encouraging data on LPCN 1144 in hypogonadal males with excess liver fat. Shares are now exchanging hands at $1.54, 3% below last Wednesday's closing price of $1.59.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424711\" data-linked=\"Lipocine completes round trip from LPCN 1144-stoked spike; shares down 7%\" data-tweet=\"$LPCN - Lipocine completes round trip from LPCN 1144-stoked spike; shares down 7% https://seekingalpha.com/news/3424711-lipocine-completes-round-trip-from-lpcn-1144-stoked-spike-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3424711-lipocine-completes-round-trip-from-lpcn-1144-stoked-spike-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424706\" data-ts=\"1548177462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424706-mimedx-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx up 18%</a></h4><ul><li>MiMedx Group (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color=\"green\">+17.7%</font>) is up on below-average volume as bargain hunters continue moving in. Shares have tripled since touching $0.97 on December 6.</li><li>Today, Okumus Fund Management <a href=\"https://www.sec.gov/Archives/edgar/data/1376339/000091957419000519/d8175203_13-g.htm\" target=\"_blank\">disclosed </a>an 11.3% stake of ~12.5M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424706\" data-linked=\"MiMedx up 18%\" data-tweet=\"$MDXG - MiMedx up 18% https://seekingalpha.com/news/3424706-mimedx-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3424706-mimedx-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424704\" data-ts=\"1548177185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424704-semis-wfe-stocks-slide-on-industry-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis, WFE stocks slide on industry forecast</a></h4><ul><li>Lynx Equity Strategies is out with a Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) earnings preview and expects further downside to the lowered capex expectations on continued weakness in DRAM pricing.</li><li>Lynx further lowers its CY19 wafer fab equipment estimate to $39B, the Street-low estimate (consensus: $42B to $45B) that represents a 20% decline.</li><li>The firm does think NAND WFE estimates might be at or near the bottom. But the double-digit DRAM pricing drop from December looks to carry on into the March quarter.</li><li>Source: Research note.</li><li>Lam Research is <font color=\"red\">down 5.1%</font> to $140.08.</li><li>WFE/NAND/DRAM companies on the move: (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-5.3%</font>), (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-1.7%</font>), (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-3.7%</font>), (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-2.5%</font>), (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='red'>-2.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3424704\" data-linked=\"Semis, WFE stocks slide on industry forecast\" data-tweet=\"$LRCX $LRCX $MU - Semis, WFE stocks slide on industry forecast https://seekingalpha.com/news/3424704-semis-wfe-stocks-slide-on-industry-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3424704-semis-wfe-stocks-slide-on-industry-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424701\" data-ts=\"1548176729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHI\" target=\"_blank\">DHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424701-homebuilders-slide-on-evidence-of-housing-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders slide on more evidence of housing dip</a></h4><ul><li>Homebuilders sink after <a href=\"https://seekingalpha.com/news/3424653-existing-home-sales-plunged-last-month\" target=\"_blank\">December existing home sales</a> fell far below expectations.</li><li>iShares U.S. Home Construction ETF (BATS:<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>) slips 1.2%; Among the ETF's top 10 holdings: D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color=\"red\">-1.3%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color=\"red\">-0.8%</font>), Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color=\"red\">-1.4%</font>), PulteGroup (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color=\"red\">-1.2%</font>), Taylor Morrison Homes (<a href='https://seekingalpha.com/symbol/TMHC' title='Taylor Morrison'>TMHC</a> <font color=\"red\">-0.8%</font>), and KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color=\"red\">-3%</font>). NVR (<a href='https://seekingalpha.com/symbol/NVR' title='NVR, Inc.'>NVR</a> <font color=\"green\">+0.2%</font>), also in ITB, is up slightly in midday trading.</li><li>Other homebuilders: Beazer Homes (<a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a> <font color=\"red\">-0.7%</font>), William Lyon Homes (<a href='https://seekingalpha.com/symbol/WLH' title='William Lyon Homes'>WLH</a> <font color=\"red\">-1.9%</font>), and Tri Pointe Homes (<a href='https://seekingalpha.com/symbol/TPH' title='TRI Pointe Group, Inc.'>TPH</a> <font color=\"red\">-2.8%</font>).</li><li>For a little perspective, ITB's one-month return is 11.6%; one-year return is -29%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3421065-homebuilders-rise-keybanc-sees-rally-dovish-fed\" target=\"_blank\">Homebuilders rise as KeyBanc sees rally on \"dovish\" Fed</a> (Jan. 7)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424701\" data-linked=\"Homebuilders slide on more evidence of housing dip\" data-tweet=\"$DHI $ITB $DHI - Homebuilders slide on more evidence of housing dip https://seekingalpha.com/news/3424701-homebuilders-slide-on-evidence-of-housing-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3424701-homebuilders-slide-on-evidence-of-housing-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424698\" data-ts=\"1548176707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GATX\" target=\"_blank\">GATX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424698-on-gatx-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on GATX Q4 results</a></h4><ul><li>GATX Corporation (<a href='https://seekingalpha.com/symbol/GATX' title='GATX Corp.'>GATX</a> <font color=\"red\">-3.4%</font>) reported Q4 revenue of $356.4M (+1% Y/Y), with lease revenue of $271.7M (-1.1% Y/Y); marine operating revenue of $65.2M (+11.6% Y/Y); and other revenue of $19.5M (-1% Y/Y).</li><li>Revenues by segments: Rail North America $235.1M (-2% Y/Y); Rail International $54.6M (+3.8% Y/Y); Portfolio Management $3.8M (-5% Y/Y) and American Steamship company $62.9M (+11.9% Y/Y).</li><li>Rail North America Q4 fleet utilization was 99.4%; Lease Price Index was negative 0.9%; average lease renewal term was 43 months and investment volume was $322.7M. Fleet of ~122,000 cars.</li><li>Rail International: GRE\u2019s fleet consisted of ~23,000 cars and Q4 fleet utilization was 98.8%, due to an improving operating environment.</li><li>ASC carried 8.5M net tons of cargo in Q4, company expects ASC to produce slightly higher segment profit in 2019, primarily due to increased tonnage.</li><li>FY19 Guidance: EPS $4.85-$5.15.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424594-gatx-beats-0_10-beats-revenue\" target=\"_blank\">GATX beats by $0.10, beats on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424698\" data-linked=\"More on GATX Q4 results\" data-tweet=\"$GATX - More on GATX Q4 results https://seekingalpha.com/news/3424698-on-gatx-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3424698-on-gatx-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424700\" data-ts=\"1548176634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UQM\" target=\"_blank\">UQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424700-uqm-technologies-leads-consumer-gainers-altria-group-and-eastman-kodak-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UQM Technologies leads consumer gainers; Altria Group and Eastman Kodak among losers</a></h4><ul><li><b>Gainers: </b>UQM Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a>) <font color=\"green\">+46%</font>. Kandi Technologies Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) <font color=\"green\">+7%</font>. Clarus (NASDAQ:<a href='https://seekingalpha.com/symbol/CLAR' title='Clarus Corporation'>CLAR</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>REV Group (NYSE:<a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a>) <font color=\"red\">-9%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a>) <font color=\"red\">-9%</font>. Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"red\">-8%</font>. Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a>) <font color=\"red\">-7%</font>. Altria Group (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424700\" data-linked=\"UQM Technologies leads consumer gainers; Altria Group and Eastman Kodak among losers\" data-tweet=\"$UQM $UQM $KNDI - UQM Technologies leads consumer gainers; Altria Group and Eastman Kodak among losers https://seekingalpha.com/news/3424700-uqm-technologies-leads-consumer-gainers-altria-group-and-eastman-kodak-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424700-uqm-technologies-leads-consumer-gainers-altria-group-and-eastman-kodak-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424695\" data-ts=\"1548175473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBWM\" target=\"_blank\">MBWM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424695-mercantile-bankplus-9-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercantile Bank +9% post Q4 results</a></h4><ul><li>Mercantile Bank (<a href='https://seekingalpha.com/symbol/MBWM' title='Mercantile Bank Corporation'>MBWM</a> <font color=\"green\">+9%</font>) <a href=\"https://seekingalpha.com/pr/17386333-mercantile-bank-corporation-announces-strong-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4</a> EPS of $0.70 vs. $0.48 in 4Q17 reflecting a higher level of earning assets and an increased net interest margin.</li><li>Net-interest margin of 3.98% vs. 3.76% in 4Q17 due to higher yield on average earning assets, primarily reflecting an increased yield on commercial loans and a change in earning asset mix, which more than offset a higher cost of funds.</li><li>New commercial term loan originations of ~$136M.</li><li>Total deposits were $2.51B, down $58.7M Y/Y.</li><li>NPA\u2019s were $5M, or 0.2% of total assets, compared to $9.4M, or 0.3% of total assets, at December 31, 2017.</li><li>Shareholders' equity totaled $375M, an increase of $9.4M from year-end 2017.</li><li>Mercantile repurchased ~0.2M shares for $5.9M, or a weighted average all-in cost/share of $29.73.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424476-mercantile-bank-declares-0_26-dividend\" target=\"_blank\">Mercantile Bank declares $0.26 dividend</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424695\" data-linked=\"Mercantile Bank +9% post Q4 results\" data-tweet=\"$MBWM - Mercantile Bank +9% post Q4 results https://seekingalpha.com/news/3424695-mercantile-bankplus-9-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3424695-mercantile-bankplus-9-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424696\" data-ts=\"1548175377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424696-gold-fields-may-seek-merger-deal-anglogold-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields may seek merger deal with AngloGold - Bloomberg</a></h4><ul><li>Gold Fields (<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+4.3%</font>) jumps following a Bloomberg report that the company <a href=\"https://finance.yahoo.com/news/gold-fields-wants-combine-rival-143015500.html\" target=\"_blank\">would like to merge</a> with larger South African rival AngloGold Ashanti (<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='green'>+2.5%</font>); GFI is out with a statement <a href=\"https://seekingalpha.com/pr/17387453-gold-fields-denies-bloomberg-story\" target=\"_blank\">refuting the story</a>.</li><li>GFI believes it would be the ideal combination as the two miners operate in similar jurisdictions and have a shared philosophy, according to the report, which also notes discussions have not occurred.</li><li>GFI's Australian assets make it attractive as a potential takeover target, although the need to turn around or sell its unprofitable South Deep mine would make a deal more difficult, says RBC analyst James Bell.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424696\" data-linked=\"Gold Fields may seek merger deal with AngloGold - Bloomberg\" data-tweet=\"$GFI $GFI $AU - Gold Fields may seek merger deal with AngloGold - Bloomberg https://seekingalpha.com/news/3424696-gold-fields-may-seek-merger-deal-anglogold-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3424696-gold-fields-may-seek-merger-deal-anglogold-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424692\" data-ts=\"1548174676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WB\" target=\"_blank\">WB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424692-weibo-slides-12-nomura-heads-to-sideline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weibo slides 12% as Nomura heads to sideline</a></h4><ul>   <li>Weibo ADRs (NASDAQ:<a href='https://seekingalpha.com/symbol/WB' title='Weibo Corporation'>WB</a>) have <font color=\"red\">slid 12.1%</font> after a cut to Neutral at Nomura Instinet.</li>    <li>That's down from Nomura's previous Buy rating. The firm lowered its price target to $61 from $74 -- which now implies 14% upside after today's double-digit move down.</li>    <li>The ADRs had closed at $60.80 on Friday.</li>    <li>Meanwhile, Weibo parent Sina (NASDAQ:<a href='https://seekingalpha.com/symbol/SINA' title='Sina Corporation'>SINA</a>) is <font color=\"red\">down 5.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424692\" data-linked=\"Weibo slides 12% as Nomura heads to sideline\" data-tweet=\"$WB $WB $SINA - Weibo slides 12% as Nomura heads to sideline https://seekingalpha.com/news/3424692-weibo-slides-12-nomura-heads-to-sideline?source=tweet\" data-url=\"https://seekingalpha.com/news/3424692-weibo-slides-12-nomura-heads-to-sideline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424688\" data-ts=\"1548174463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCC\" target=\"_blank\">BCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424688-boise-cascade-names-nate-jorgensen-coo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boise Cascade names Nate Jorgensen as COO</a></h4><ul><li>Boise Cascade (<a href='https://seekingalpha.com/symbol/BCC' title='Boise Cascade Company'>BCC</a> <font color='red'>-4%</font>) has <a href=\"https://seekingalpha.com/pr/17386948-boise-cascade-announces-officer-promotions-retirements\" target=\"_blank\">promoted</a> Nate Jorgensen to the position of COO. Nate Jorgensen has 32 years of experience in the industry and has served at Boise Cascade since 2015.</li><li>Most recently, he led the engineered wood products sales and marketing organization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424688\" data-linked=\"Boise Cascade names Nate Jorgensen as COO\" data-tweet=\"$BCC - Boise Cascade names Nate Jorgensen as COO https://seekingalpha.com/news/3424688-boise-cascade-names-nate-jorgensen-coo?source=tweet\" data-url=\"https://seekingalpha.com/news/3424688-boise-cascade-names-nate-jorgensen-coo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424687\" data-ts=\"1548174358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424687-oil-service-stocks-slide-amid-halliburton-earnings-crude-oil-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil service stocks slide amid Halliburton earnings, crude oil plunge</a></h4><ul><li>Oil service stocks are reversing Friday's big gains, with the  OSX Index dropping as much as 4.2% following bellwether  Halliburton\u2019s (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-5.4%</font>) <a href=\"https://seekingalpha.com/news/3424540-halliburton-minus-1-percent-north-american-activity-slows\" target=\"_blank\">Q4 results</a> and <a href=\"https://www.cnbc.com/2019/01/22/oil-markets-global-economic-growth-in-focus.html\" target=\"_blank\">crude oil's sharp drop</a> amid more signs of an economic slowdown in China, sparking concerns about global growth and fuel demand.</li><li>WTI crude oil <font color=\"red\">-3.3%</font> to $52.02/bbl, Brent <font color=\"red\">-2.9%</font> to $60.91/bbl.</li><li>Stifel analyst Stephen Gengaro says \"back of the envelope math\" suggests the midpoint of HAL\u2019s Q1 guidance implies  EPS in the $0.22-$0.24 range vs. analyst consensus $0.31, according to Bloomberg First Word.</li><li>Stephens analyst Tommy Moll is positive on HAL\u2019s comments of \"modest\" improvement in Q1 fracking activity, but E&amp;P budget cuts and additional pressure pumper commentary likely are a larger negative for sector sentiment.</li><li>The number of active hydraulic fracturing fleets in the Permian Basin <a href=\"https://finance.yahoo.com/news/halliburton-posts-fourth-quarter-profit-115311393.html\" target=\"_blank\">fell to 140 in January from 192 in June 2018</a>, according to data from consultancy Primary Vision.</li><li>Today losers include <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color=\"red\">-7.6%</font>, <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color=\"red\">-5.8%</font>, <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color=\"red\">-5.5%</font>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color=\"red\">-4.9%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-4.8%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/OIS' title='Oil States International Inc.'>OIS</a> <font color=\"red\">-3.7%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"red\">-1.9%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color=\"red\">-1.8%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color=\"red\">-1.6%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424687\" data-linked=\"Oil service stocks slide amid Halliburton earnings, crude oil plunge\" data-tweet=\"$HAL $HAL $WFTIQ - Oil service stocks slide amid Halliburton earnings, crude oil plunge https://seekingalpha.com/news/3424687-oil-service-stocks-slide-amid-halliburton-earnings-crude-oil-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3424687-oil-service-stocks-slide-amid-halliburton-earnings-crude-oil-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424677\" data-ts=\"1548173103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDWD\" target=\"_blank\">MDWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424677-mimedx-group-and-mediwound-among-healthcare-gainers-editas-medicine-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx Group and MediWound among healthcare gainers; Editas Medicine leads the losers</a></h4><ul><li><b>Gainers: </b>MediWound (NASDAQ:<a href='https://seekingalpha.com/symbol/MDWD' title='Mediwound Ltd.'>MDWD</a>) <font color=\"green\">+29%</font>. Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) <font color=\"green\">+17% </font>MiMedx Group (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>) <font color=\"green\">+15%</font>. MYnd Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a>) <font color=\"green\">+13%</font>. Restoration Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>Editas Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>) <font color=\"red\">-21%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a>) <font color=\"red\">-19%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-18%</font>. Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"red\">-16%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"red\">-15%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424677\" data-linked=\"MiMedx Group and MediWound among healthcare gainers; Editas Medicine leads the losers\" data-tweet=\"$MDWD $MDWD $TMDI - MiMedx Group and MediWound among healthcare gainers; Editas Medicine leads the losers https://seekingalpha.com/news/3424677-mimedx-group-and-mediwound-among-healthcare-gainers-editas-medicine-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424677-mimedx-group-and-mediwound-among-healthcare-gainers-editas-medicine-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424676\" data-ts=\"1548172974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNED\" target=\"_blank\">BNED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424676-barnes-noble-education-rallies-after-sidoti-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble Education rallies after Sidoti upgrade</a></h4><ul> <li>Barnes &amp; Noble Education (<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc'>BNED</a> <font color='green'>+6.8%</font>) breaks higher on elevated volume after Sidoti upgrades the college bookstore operator to a Buy rating from Neutral.</li> <li>BNED still trades slightly below the mid-point of its 52-week range of $3.58 to $8.32.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3424676\" data-linked=\"Barnes &amp; Noble Education rallies after Sidoti upgrade\" data-tweet=\"$BNED - Barnes &amp; Noble Education rallies after Sidoti upgrade https://seekingalpha.com/news/3424676-barnes-noble-education-rallies-after-sidoti-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3424676-barnes-noble-education-rallies-after-sidoti-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424674\" data-ts=\"1548172838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDIT\" target=\"_blank\">EDIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424674-editas-weighs-on-gene-therapy-players\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Editas weighs on gene therapy players</a></h4><ul><li>Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color=\"red\">-21.1%</font>) is leading many gene therapy firms in the red after its CEO <a href=\"https://seekingalpha.com/news/3424636-editas-ceo-bids-adieu-shares-18-percent\" target=\"_blank\">announced </a>her planned departure. Citigroup added to the bearishness with its <a href=\"https://seekingalpha.com/news/3424548-citi-cuts-crispr-therapeutics-sell-shares-7-percent-premarket\" target=\"_blank\">downgrade </a>of CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color=\"red\">-12.1%</font>) to Sell.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/MGTX' title='MeiraGTx Holdings plc'>MGTX</a> <font color=\"red\">-0.4%</font>)(<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"red\">-3.2%</font>)(<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color=\"red\">-4.9%</font>)(<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color=\"red\">-2.5%</font>)(<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a> <font color=\"red\">-4.2%</font>)(<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"red\">-3.6%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color=\"red\">-8%</font>)(<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color=\"red\">-3.5%</font>)(<a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics'>BOLD</a> <font color=\"red\">-4.2%</font>)(<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color=\"red\">-3.8%</font>)(<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color=\"red\">-3.8%</font>)(<a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a> <font color=\"red\">-2.3%</font>)(<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-3.7%</font>)(<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color=\"red\">-3.4%</font>)(<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color=\"red\">-0.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424674\" data-linked=\"Editas weighs on gene therapy players\" data-tweet=\"$EDIT $EDIT $CRSP - Editas weighs on gene therapy players https://seekingalpha.com/news/3424674-editas-weighs-on-gene-therapy-players?source=tweet\" data-url=\"https://seekingalpha.com/news/3424674-editas-weighs-on-gene-therapy-players\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424673\" data-ts=\"1548172641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLR\" target=\"_blank\">DLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424673-digital-realty-expanding-internet-exchange-chicago-northern-virginia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Realty expanding Internet exchange into Chicago, Northern Virginia</a></h4><ul>   <li>Digital Realty (<a href=\"http://seekingalpha.com/symbol/DLR\" target=\"_blank\">DLR</a> <font color=\"red\">-2.4%</font>) has announced plans to expand its Internet Exchange Platform into <a href=\"https://seekingalpha.com/pr/17386080-digital-realty-expands-internet-exchange-platform-chicago-northern-virginia\" target=\"_blank\">Chicago and Northern Virginia</a>, extending beyond its current four metros.</li>    <li>It's expanding its DRIX platform to a data center in Ashburn, Va., building on its co-location footprint in the world's biggest data-center market.</li>    <li>The Chicago move represents an expansion of the network hub for Internet traffic in the Midwestern U.S.</li>    <li>The two locations expand beyond the existing DRIX network in New York, Atlanta, Dallas and Phoenix.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424673\" data-linked=\"Digital Realty expanding Internet exchange into Chicago, Northern Virginia\" data-tweet=\"$DLR - Digital Realty expanding Internet exchange into Chicago, Northern Virginia https://seekingalpha.com/news/3424673-digital-realty-expanding-internet-exchange-chicago-northern-virginia?source=tweet\" data-url=\"https://seekingalpha.com/news/3424673-digital-realty-expanding-internet-exchange-chicago-northern-virginia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424666\" data-ts=\"1548172163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424666-allegheny-technologies-down-4-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Technologies down 4% post Q4 results</a></h4><ul><li>Allegheny Technologies (<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color=\"red\">-4.4%</font>) reported Q4 sales growth of 14.3% Y/Y to $1.04B.</li><li>Segment Sales: High Performance Materials &amp; Components sales +15.1% Y/Y to $596.1M, due to higher sales of next-generation jet engine products; and Flat Rolled Products sales +12.7% Y/Y to $441.8M.</li><li>Revenue % by market: Jet Engines 29%; Airframes 14%; Government Aerospace &amp; Defense 7%; Oil &amp; Gas 13%; Automotive 8%; Food Equipment &amp; Appliances 6%; Electrical Energy 5%; Construction/Mining 5%; Medical 4%; Electronics/Computers/Communications 5%; and others 4%.</li><li>Q4 Gross margin <font color=\"red\">declined by 145 bps</font> to 14.2%.</li><li>Q4 Overall operating margin <font color=\"red\">declined by 130 bps</font> to 8.4%; High Performance Materials &amp; Components was flat at 12.7%; and Flat Rolled Products <font color=\"red\">declined by 310 bps</font> to 2.6%, negatively impacted by significant price declines in several key raw materials.</li><li>Cash provided by operating activities was $392.8M, as compared to $22.4M a year ago.</li><li>Company reported Cash and cash equivalents of $382M, as of December 31, 2018.</li><li>2019 Outlook: In HPMC segment ATI expects high-single-digit revenue growth, and Y/Y segment operating profit margin improvement of 150 bps. For FRP segment ATI expects results for FY19 to be in line with 2018. ATI expects strong cash flow generation from operations, with free cash flow, of at least $290M; and Capital expenditures between $165M and $170M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424531-allegheny-technologies-misses-0_03-beats-revenue\" target=\"_blank\">Allegheny Technologies misses by $0.03, beats on revenue</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424666\" data-linked=\"Allegheny Technologies down 4% post Q4 results\" data-tweet=\"$ATI - Allegheny Technologies down 4% post Q4 results https://seekingalpha.com/news/3424666-allegheny-technologies-down-4-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3424666-allegheny-technologies-down-4-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424670\" data-ts=\"1548172093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424670-goldman-provides-color-on-168-share-target-on-ligand-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman provides color on $168/share target on Ligand Pharma</a></h4><ul><li>Goldman Sachs analyst Dana Flanders provides the numbers behind his Street-low fair value target of $168 (46% upside) for Ligand Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color=\"red\">-2.1%</font>) which makes money via licensing deals.</li><li>He values its base business at $47/share, assuming that Novartis' Promacta (eltrombopag) and Amgen's Kyprolis (carfilzomib) reach $1.7B in peak sales and won't face generic competition until 2024 and 2026, respectively.</li><li>Mr. Flanders has $550M in milestones in his model through 2032, on the conservative side considering that the company says its $3B milestone target does not include all of the expected $1.5B from Viking Therapeutics' pipeline.</li><li>His price target assumes $21/share for preclinical and future partnerships, $16/share from Phase 1 assets, $21/share from Phase 2 assets and $15/share from Phase 3 assets.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3424670\" data-linked=\"Goldman provides color on $168/share target on Ligand Pharma\" data-tweet=\"$LGND - Goldman provides color on $168/share target on Ligand Pharma https://seekingalpha.com/news/3424670-goldman-provides-color-on-168-share-target-on-ligand-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3424670-goldman-provides-color-on-168-share-target-on-ligand-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424665\" data-ts=\"1548171287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424665-eldorado-goldminus-3-q4-output-falls-10-lamaque-on-track-for-q1-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold -3% as Q4 output falls 10%; Lamaque on track for Q1 start</a></h4><ul><li>Eldorado Gold (<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color=\"red\">-3%</font>) is lower after reporting <a href=\"https://seekingalpha.com/pr/17386187-eldorado-gold-announces-q4-full-year-2018-production-cash-costs\" target=\"_blank\">Q4 gold production fell nearly 10% Y/Y</a> to 75,877 oz. from ~84K oz. in the year-ago period.</li><li>For the full year, total production rose 16% Y/Y to 349,147 oz. of gold, which  beat the company\u2019s target of 290K-330K oz., but all-in sustaining costs rose 7% to $990/oz. sold from $922/oz. sold in 2017.</li><li>EGO says commercial production from the Lamaque mine in Quebec is set to be declared starting in Q1 2019, with an anticipated annual output of 123K gold oz. at all-in sustaining costs of $634/oz. over 10 years.</li><li>EGO offers <a href=\"http://www.mining.com/eldorado-gold-countdown-opening-first-mine-canada/\" target=\"_blank\">no update on the status</a> of its application to obtain \u20ac750M ($851M) in compensation from Greece for damages suffered due to delays in the issuance of permits for its Skouries project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424665\" data-linked=\"Eldorado Gold -3% as Q4 output falls 10%; Lamaque on track for Q1 start\" data-tweet=\"$EGO - Eldorado Gold -3% as Q4 output falls 10%; Lamaque on track for Q1 start https://seekingalpha.com/news/3424665-eldorado-goldminus-3-q4-output-falls-10-lamaque-on-track-for-q1-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3424665-eldorado-goldminus-3-q4-output-falls-10-lamaque-on-track-for-q1-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424663\" data-ts=\"1548170689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARE\" target=\"_blank\">RARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424663-ultragenyxs-ux007-shows-sustained-effect-in-inherited-metabolic-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultragenyx&#39;s UX007 shows sustained effect in inherited metabolic disorder</a></h4><ul><li>Data from a long-term extension study evaluating Ultragenyx Pharmaceutical's (<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color=\"red\">-3.9%</font>) UX007 in patients with long-chain fatty acid oxidation disorder (LC-FAOD) showed a durable effect albeit with side effects.</li><li>LC-FAOD is an inherited disease in which sufferers lack the necessary enzymes to convert fat to energy.</li><li>In 24 patients who completed 78 weeks of treatment in the <a href=\"https://clinicaltrials.gov/ct2/show/NCT01886378?intr=ux007&amp;lead=ultragenyx&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 trial</a>, then received an additional 78 weeks of therapy in the extension phase, the median annualized event rate dropped to zero from 0.7.</li><li>On the safety front, the most common treatment-related adverse events were diarrhea, vomiting and abdominal pain. There was one discontinuation related to treatment and two deaths, neither determined to be related to UX007.</li><li>The company says it expects to file a U.S. marketing application by mid-year.</li><li><a href=\"http://www.ultragenyx.com/pipeline/triheptanoin-faod/\" target=\"_blank\">UX007 </a>is a purified pharmaceutical-grade form of a triglyceride compound called triheptanoin that provides patients with medium-length odd-chain fatty acids which increase the intermediate substrates in the Krebs cycle, a key energy-generating process, which produces new glucose.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424663\" data-linked=\"Ultragenyx&#39;s UX007 shows sustained effect in inherited metabolic disorder\" data-tweet=\"$RARE - Ultragenyx&#39;s UX007 shows sustained effect in inherited metabolic disorder https://seekingalpha.com/news/3424663-ultragenyxs-ux007-shows-sustained-effect-in-inherited-metabolic-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3424663-ultragenyxs-ux007-shows-sustained-effect-in-inherited-metabolic-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424656\" data-ts=\"1548169616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CABO\" target=\"_blank\">CABO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424656-cable-oneplus-1_6-keybanc-boosts-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cable One +1.6% as KeyBanc boosts to Overweight</a></h4><ul>   <li>Cable One (NYSE:<a href='https://seekingalpha.com/symbol/CABO' title='Cable One, Inc.'>CABO</a>) is <font color=\"green\">up 1.6%</font> after an upgrade to Overweight by KeyBanc, from Sector Weight.</li>    <li>The bank set its price target at $1,025, now implying 19% upside.</li>    <li>After a steady climb through much of 2018, shares have leveled off in the past few months; they're <font color=\"green\">up 18.6%</font> over the past 12 months but <font color=\"red\">down 2.7%</font> over the past three.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424656\" data-linked=\"Cable One +1.6% as KeyBanc boosts to Overweight\" data-tweet=\"$CABO - Cable One +1.6% as KeyBanc boosts to Overweight https://seekingalpha.com/news/3424656-cable-oneplus-1_6-keybanc-boosts-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3424656-cable-oneplus-1_6-keybanc-boosts-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424651\" data-ts=\"1548169231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424651-pg-and-e-obtains-5_5b-in-debtor-in-possession-financing-sharesplus-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E obtains $5.5B in debtor-in-possession financing; shares +8%</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+8.4%</font>) shoots higher on news it has lined up <a href=\"https://www.wsj.com/articles/pg-e-lines-up-5-5-billion-dip-financing-11548168135\" target=\"_blank\">$5.5B in debtor-in-possession financing</a> from JPMorgan Chase, Bank of America, Barclays and Citigroup, according to an <a href=\"https://www.sec.gov/Archives/edgar/data/75488/000095015719000075/form8-k.htm\" target=\"_blank\">SEC filing</a>.</li><li>The financing includes a $3.5B revolving credit facility, a $1.5B term loan facility and a $500M delayed draw term loan facility.</li><li>PG&amp;E also enters into a debt commitment letter under which JPMorgan will provide a $250M senior secured bridge loan facility.</li><li>PG&amp;E expects DIP financing will provide sufficient liquidity to fund its ongoing operations, including its ability to provide safe service to customers during its Chapter 11 process, which it expects will take about two years, with the potential for a one-year extension through the DIP facilities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424651\" data-linked=\"PG&amp;E obtains $5.5B in debtor-in-possession financing; shares +8%\" data-tweet=\"$PCG - PG&amp;E obtains $5.5B in debtor-in-possession financing; shares +8% https://seekingalpha.com/news/3424651-pg-and-e-obtains-5_5b-in-debtor-in-possession-financing-sharesplus-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3424651-pg-and-e-obtains-5_5b-in-debtor-in-possession-financing-sharesplus-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424647\" data-ts=\"1548168551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424647-chinese-internet-stocks-slide-on-ad-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese internet stocks slide on ad challenges</a></h4><ul><li>Mizuho analyst James Lee says Chinese internet stocks will continue to face ad challenges in 2019 as macro headwinds weigh on high-priced verticals.</li><li>Lee cites checks with both advertisers, and internet companies.</li><li>China's resumption of game approvals might provide some relief and Lee sees consumer staples as another of the few sectors that could see increasing ad spend.</li><li>The analyst reiterates Alibaba (<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='red'>-2.2%</font>) as a top pick in this \"defensive environment.\"</li><li>More action: Baird trims its FY19 estimates on Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='red'>-3.8%</font>) on macro softness.</li><li>Source: Bloomberg First Word.</li><li>Other Chinese internet stocks: (<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a> <font color='red'>-3.2%</font>), (<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a> <font color='red'>-2.4%</font>), (<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a> <font color='red'>-4.2%</font>), (<a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a> <font color='red'>-3.9%</font>), (<a href='https://seekingalpha.com/symbol/BILI' title='Bilibili'>BILI</a> <font color='red'>-5%</font>), (<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a> <font color='red'>-1.6%</font>), (<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a> <font color='red'>-4.2%</font>).</li><li>Related China tech ETFs: <a href='https://seekingalpha.com/symbol/KWEB' title='KraneShares CSI China Internet ETF'>KWEB</a>, <a href='https://seekingalpha.com/symbol/CQQQ' title='Invesco China Technology ETF'>CQQQ</a>, <a href='https://seekingalpha.com/symbol/QQQC-OLD' title='Global X China Technology ETF'>QQQC-OLD</a>, <a href='https://seekingalpha.com/symbol/CWEB' title='Direxion Daily CSI China Internet Index Bull 2x Shares ETF'>CWEB</a>, <a href='https://seekingalpha.com/symbol/CHIK' title='Global X MSCI China Information Technology ETF'>CHIK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424647\" data-linked=\"Chinese internet stocks slide on ad challenges\" data-tweet=\"$BABA $BABA $BIDU - Chinese internet stocks slide on ad challenges https://seekingalpha.com/news/3424647-chinese-internet-stocks-slide-on-ad-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3424647-chinese-internet-stocks-slide-on-ad-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424645\" data-ts=\"1548168514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSDT\" target=\"_blank\">HSDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424645-helius-medical-tech-down-7-on-bearish-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helius Medical Tech down 7% on bearish report</a></h4><ul><li>Thinly traded micro cap Helius Medical Technologies (<a href='https://seekingalpha.com/symbol/HSDT' title='Helius Medical Technologies, Inc.'>HSDT</a> <font color=\"red\">-7%</font>) is down out the gate this morning on the heels of a <a href=\"https://seekingalpha.com/article/4234256-helius-medical-failed-clinical-trial-redacted-data-questionable-leadership-points-ineffective\" target=\"_blank\">bearish article</a> from SA Contributor White Diamond Research.</li><li>WDR questions the effectiveness of its device to treat brain injury and cites the dubious background of the former CEO who now supposedly on the lamb.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424645\" data-linked=\"Helius Medical Tech down 7% on bearish report\" data-tweet=\"$HSDT - Helius Medical Tech down 7% on bearish report https://seekingalpha.com/news/3424645-helius-medical-tech-down-7-on-bearish-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3424645-helius-medical-tech-down-7-on-bearish-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424643\" data-ts=\"1548168139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424643-comscore-expands-deal-nbcu-owned-stations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore expands deal with NBCU owned stations</a></h4><ul>   <li>ComScore (NASDAQ:<a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a>) has formed an <a href=\"https://seekingalpha.com/pr/17387145-comscore-expands-partnership-nbc-telemundo-owned-stations-full-group-deal\" target=\"_blank\">expanded partnership</a> with an NBCUniversal (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"red\">-0.7%</font>) unit that includes dozens of owned TV stations.</li>    <li>ComScore is <font color=\"green\">up 4.1%</font>.</li>    <li>The deal with NBCUniversal Owned Television Stations covers 40 stations owned by NBCU and Telemundo, all of which will use comScore's linear TV currency along with local mobile and desktop insights.</li>    <li>The deal also includes comScore's automotive, political and consumer targeting segments.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424643\" data-linked=\"ComScore expands deal with NBCU owned stations\" data-tweet=\"$SCOR $SCOR $CMCSA - ComScore expands deal with NBCU owned stations https://seekingalpha.com/news/3424643-comscore-expands-deal-nbcu-owned-stations?source=tweet\" data-url=\"https://seekingalpha.com/news/3424643-comscore-expands-deal-nbcu-owned-stations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424636\" data-ts=\"1548167524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDIT\" target=\"_blank\">EDIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424636-editas-ceo-bids-adieu-shares-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Editas CEO bids adieu; shares down 18%</a></h4><ul><li>Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color=\"red\">-17.6%</font>) President &amp; CEO Katrine Bosley will <a href=\"https://seekingalpha.com/pr/17387127-editas-medicine-announces-chief-executive-officer-transition\" target=\"_blank\">resign </a>effective March 1. Board member Cynthia Collins will take the helm on an interim basis until a permanent successor is hired.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424636\" data-linked=\"Editas CEO bids adieu; shares down 18%\" data-tweet=\"$EDIT - Editas CEO bids adieu; shares down 18% https://seekingalpha.com/news/3424636-editas-ceo-bids-adieu-shares-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3424636-editas-ceo-bids-adieu-shares-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424634\" data-ts=\"1548167332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDD\" target=\"_blank\">PDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424634-pinduoduominus-5-after-coupon-hack-lockup-expiration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinduoduo -5% after coupon hack, lockup expiration</a></h4><ul><li>Hackers <a href=\"https://www.bloomberg.com/news/articles/2019-01-20/hackers-take-coupons-worth-tens-of-millions-of-yuan-on-pinduoduo\" target=\"_blank\">stole coupons </a>worth tens of millions of yuan through a vulnerability in Pinduoduo's (NASDAQ:<a href='https://seekingalpha.com/symbol/PDD' title='Pinduoduo'>PDD</a>) platform.</li><li>The company says the problem has been fixed and the matter reported to the police.</li><li>PDD is <font color=\"red\">down 4.7%</font> premarket to $23.82. Note that the company's IPO lockup expiration is today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424634\" data-linked=\"Pinduoduo -5% after coupon hack, lockup expiration\" data-tweet=\"$PDD - Pinduoduo -5% after coupon hack, lockup expiration https://seekingalpha.com/news/3424634-pinduoduominus-5-after-coupon-hack-lockup-expiration?source=tweet\" data-url=\"https://seekingalpha.com/news/3424634-pinduoduominus-5-after-coupon-hack-lockup-expiration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424628\" data-ts=\"1548167052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424628-expanded-use-for-amgens-blincyto-okd-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expanded use for Amgen&#39;s Blincyto OK&#39;d in Europe</a></h4><ul><li>The European Commission <a href=\"https://seekingalpha.com/pr/17387058-european-commission-approves-blincyto-blinatumomab-patients-philadelphia-chromosome-negative\" target=\"_blank\">approves </a>the use of Amgen's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) BLINCYTO (blinatumomab) as monotherapy to treat adult patients with Philadelphia chromosome-negative CD19- positive B-cell precursor acute lymphoblastic leukemia &#40;ALL&#41; in first or second complete remission with minimal residual disease &#40;MRD&#41; greater than or equal to 0.1 percent.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424628\" data-linked=\"Expanded use for Amgen&#39;s Blincyto OK&#39;d in Europe\" data-tweet=\"$AMGN - Expanded use for Amgen&#39;s Blincyto OK&#39;d in Europe https://seekingalpha.com/news/3424628-expanded-use-for-amgens-blincyto-okd-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3424628-expanded-use-for-amgens-blincyto-okd-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424623\" data-ts=\"1548166724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424623-gapminus-4-after-goldman-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap -4% after Goldman cut</a></h4><ul> <li>Goldman Sachs lowers Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>) to a Sell rating on concerns that management's rationalization efforts won't lead to a turnaround amid the promotional environment.</li> <li>The firm takes its price target on Gap down to $23 from $27.</li> <li>Shares of Gap are <font color=\"red\">down 4.07%</font> in premarket trading to $24.95. The 52-week for the retailer is $24.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424623\" data-linked=\"Gap -4% after Goldman cut\" data-tweet=\"$GPS - Gap -4% after Goldman cut https://seekingalpha.com/news/3424623-gapminus-4-after-goldman-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3424623-gapminus-4-after-goldman-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424622\" data-ts=\"1548166639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAF\" target=\"_blank\">STAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424622-apha-ebay-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APHA, EBAY among premarket gainers</a></h4><ul><li>Staffing 360 Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a>) <font color=\"green\">+50%</font> on <a href=\"https://seekingalpha.com/pr/17386736-staffing-360-solutions-re-signs-largest-client-multi-year-contract\" target=\"_blank\">re-signing</a> largest client to multi-year contract.</li><li>UQM Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a>) <font color=\"green\">+45%</font> on being <a href=\"https://seekingalpha.com/news/3424459-uqm-technologies-acquired-danfoss\" target=\"_blank\">acquired</a> by Danfoss.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+18%</font> <a href=\"https://seekingalpha.com/news/3424615-bio-path-24-percent-premarket\" target=\"_blank\">after</a> last week's <font color=\"red\">62%</font> plunge in response to its stock offering and 1:20 reverse split.</li><li>MediWound (NASDAQ:<a href='https://seekingalpha.com/symbol/MDWD' title='Mediwound Ltd.'>MDWD</a>) <font color=\"green\">+18%</font> on <a href=\"https://seekingalpha.com/news/3424523-mediwound-36-percent-premarket-positive-nexobrid-data\" target=\"_blank\">positive</a> NexoBrid data.</li><li>Kitov Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a>) <font color=\"green\">+13%</font> on <a href=\"https://seekingalpha.com/pr/17385445-kitov-closes-6-million-registered-direct-offering\" target=\"_blank\">closing</a> $6 Million Registered Direct Offering.</li><li>eBay (NASDAQ:<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/news/3424586-activist-letter-sends-ebay-12-percent\" target=\"_blank\">activist letter</a> for a plan of action.</li><li>TG Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3424598-tg-therapeutics-11-percent-receiving-breakthrough-therapy-designation-umbralisib\" target=\"_blank\">receiving</a> Breakthrough Therapy Designation for umbralisib.</li><li>Ryanair Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/RYAAY' title='Ryanair Holdings PLC'>RYAAY</a>) <font color=\"green\">+9%</font>.</li><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+6%</font>.</li><li>New Oriental Education &amp; Technology (NYSE:<a href='https://seekingalpha.com/symbol/EDU' title='New Oriental Education & Technology Group Inc.'>EDU</a>) <font color=\"green\">+6%</font> on Q2 <a href=\"https://seekingalpha.com/news/3424470-new-oriental-education-and-technology-beats-0_26-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Gevo (NASDAQ:<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17386999-gevo-working-san-francisco-international-airport-consortium-advance-sustainable-aviation-fuel\" target=\"_blank\">joining</a> with the San Francisco International Airport, certain airlines and other industry participants for the use and advancement of sustainable aviation fuels.</li><li>Remark Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17386819-remark-holdings-announces-preliminary-4q-2018-revenues-26_6-million-26_8-million\" target=\"_blank\">preliminary</a> 4Q18 revenues between $26.6M-$26.8M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424622\" data-linked=\"APHA, EBAY among premarket gainers\" data-tweet=\"$STAF $STAF $UQM - APHA, EBAY among premarket gainers https://seekingalpha.com/news/3424622-apha-ebay-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3424622-apha-ebay-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424621\" data-ts=\"1548166627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424621-neovasc-up-28-premarket-on-settlement-of-patent-infringement-action-edwards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc up 28% premarket on settlement of patent infringement action by Edwards</a></h4><ul><li>Nano cap Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) is up <font color=\"green\">28%</font> premarket on robust volume following its <a href=\"https://seekingalpha.com/pr/17386564-neovasc-announces-dismissal-claim-brought-edwards-lifesciences\" target=\"_blank\">announcement </a>that Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>) has settled its patent infringement action in Canada against the company and the case will be dismissed on a no-costs basis.</li><li>The dispute appears to be with Edwards unit CardiAQ over its Tiara valve, although the press release is not specific.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424621\" data-linked=\"Neovasc up 28% premarket on settlement of patent infringement action by Edwards\" data-tweet=\"$NVCN $NVCN $EW - Neovasc up 28% premarket on settlement of patent infringement action by Edwards https://seekingalpha.com/news/3424621-neovasc-up-28-premarket-on-settlement-of-patent-infringement-action-edwards?source=tweet\" data-url=\"https://seekingalpha.com/news/3424621-neovasc-up-28-premarket-on-settlement-of-patent-infringement-action-edwards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424615\" data-ts=\"1548165816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424615-bio-path-up-24-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bio-Path up 24% premarket</a></h4><ul><li>Thinly traded nano cap Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) is up <font color=\"green\">24% </font>premarket on modestly higher volume as bargain hunters move in after last week's <font color=\"red\">62%</font> plunge in response to its stock offering and 1:20 reverse split.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424615\" data-linked=\"Bio-Path up 24% premarket\" data-tweet=\"$BPTH - Bio-Path up 24% premarket https://seekingalpha.com/news/3424615-bio-path-up-24-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3424615-bio-path-up-24-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424611\" data-ts=\"1548165666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424611-northern-oil-sees-q4-production-in-upper-half-of-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil sees Q4 production in upper half of guidance</a></h4><ul><li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color=\"green\">+2.8%</font> pre-market after saying it expects Q4 production to <a href=\"https://seekingalpha.com/pr/17386403-northern-oil-gas-inc-provides-fourth-quarter-2018-update-initial-share-repurchase-activity\" target=\"_blank\">finish in the upper half</a> of the company's previous guidance of 35K-36K boe per day, despite curtailments and shut-ins during a turbulent quarter for in-basin realized prices.</li><li>NOG says it enjoyed strong cash flows during Q4, reducing the amount drawn on the its revolving credit facility to $140M at year-end 2018, a $35 million reduction from the previously announced balance on Nov. 5.</li><li>The company says it expects to generate strong cash flow from operations in 2019       that will exceed its capital spending budget.</li><li>NOG says Q4 lease operating expenses were better than anticipated, thus full year average LOE is now expected to come in slightly below the low end of prior guidance of $7.50-$7.75/bbl.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424611\" data-linked=\"Northern Oil sees Q4 production in upper half of guidance\" data-tweet=\"$NOG - Northern Oil sees Q4 production in upper half of guidance https://seekingalpha.com/news/3424611-northern-oil-sees-q4-production-in-upper-half-of-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3424611-northern-oil-sees-q4-production-in-upper-half-of-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424609\" data-ts=\"1548165534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVC\" target=\"_blank\">IVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424609-invacare-up-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invacare up 22% premarket</a></h4><ul><li>Invacare (NYSE:<a href='https://seekingalpha.com/symbol/IVC' title='Invacare Corporation'>IVC</a>) is up <font color=\"green\">22%</font> premarket on light volume on the heels of an <a href=\"https://baseballnewssource.com/2019/01/22/invacare-ivc-upgraded-at-valuengine/3156854.html\" target=\"_blank\">upgrade</a> to Hold at ValuEngine.</li><li>On the working capital front, at the end of September 2018, it had $118.3M in cash and equivalents while operations consumed $49.5M during the first three quarter of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424609\" data-linked=\"Invacare up 22% premarket\" data-tweet=\"$IVC - Invacare up 22% premarket https://seekingalpha.com/news/3424609-invacare-up-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3424609-invacare-up-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424608\" data-ts=\"1548165486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424608-kandiplus-8-after-ride-sharing-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi +8% after ride-sharing development</a></h4><ul> <li>Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) announces that its JV with Geely Group led the efforts in organizing a five-year online ride-sharing service alliance in Hangzhou on January 13.</li><li>The goal of the ride-sharing program is to provide 300K government-accredited vehicles within five years. Participating companies from more than ten cities including Beijing, Tianjin, Shenzhen, Chengdu, Suzhou, Guangzhou, and Xiamen jointly signed the alliance agreement.</li><li>Last week, the JV  signed a framework agreement with Zhejiang Ruibo to provide the 300K government-accredited vehicles for the ride-sharing service within five years as the primary vehicle supplier.</li>   <li>Kandi on the ride-sharing opportunity: \"The related state department is aiming to impose restrictions on car-sharing operations to legalize and standardize the industry. We believe that 2019 will be the perfect time to rectify the use of non-government-accredited ride-sharing vehicles, as well as to mark the entry point for pure electric vehicles being officially introduced to the ride-sharing market...  Given Kandi\u2019s specialty in producing quick-change batteries for pure electric vehicles, getting into the online ride-sharing market would have inherent advantages for the Company.\"</li>  <li>KNDI  <font color=\"green\">+7.55%</font> premarket to  $5.46.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17386899-kandi-signs-framework-agreement-zhejiang-ruibo-serve-primary-vehicle-provider-300000-electric\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3424608\" data-linked=\"Kandi +8% after ride-sharing development\" data-tweet=\"$KNDI - Kandi +8% after ride-sharing development https://seekingalpha.com/news/3424608-kandiplus-8-after-ride-sharing-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3424608-kandiplus-8-after-ride-sharing-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424604\" data-ts=\"1548165125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424604-elliott-management-turns-up-heat-on-ebay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott Management turns up the heat on eBay</a></h4><ul> <li>Elliott Management has a plan of action for eBay (NASDAQ:<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a>) to increase shareholder value.</li> <li>The activist firm thinks eBay should launch a comprehensive portfolio review. \"StubHub and eBay\u2019s portfolio of Classifieds properties represent high-value, strategic assets that are worth meaningfully more than the value currently being ascribed to them as part of eBay. In addition to unlocking substantial value, separating from these assets would allow eBay\u2019s management team to refocus its efforts on the core Marketplace business,' reads the Elliott missive.</li> <li>Also part of the Elliott plan for eBay are \"substantial\" capital allocation to shareholders, a stronger focus on the Marketplace business and operational improvements with an aim at boosting margins.</li> <li>Shares of eBay are <font color=\"green\">up 11.58%</font> in premarket trading to $34.59. The last time eBay swapped hands at over $34 was back in September.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424586-activist-letter-sends-ebay-12-percent\" target=\"_blank\">Activist letter sends eBay up 12%</a> (Jan. 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424604\" data-linked=\"Elliott Management turns up the heat on eBay\" data-tweet=\"$EBAY - Elliott Management turns up the heat on eBay https://seekingalpha.com/news/3424604-elliott-management-turns-up-heat-on-ebay?source=tweet\" data-url=\"https://seekingalpha.com/news/3424604-elliott-management-turns-up-heat-on-ebay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424603\" data-ts=\"1548165004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424603-sorrento-up-7-premarket-on-positive-resiniferatoxin-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento up 7% premarket on positive resiniferatoxin data</a></h4><ul><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) is up <font color=\"green\">7%</font> premarket on modest volume following its <a href=\"https://seekingalpha.com/pr/17386492-sorrento-therapeutics-announces-interim-results-osteoarthritis-knee-pain-phase-1b-trial\" target=\"_blank\">announcement </a>of preliminary data from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03542838?term=NCT03542838&amp;rank=1\" target=\"_blank\">Phase 1b clinical trial</a> evaluating non-opioid afferent nerve-ablating drug candidate resiniferatoxin &#40;RTX&#41; in patients with knee osteoarthritis.</li><li>Rapid pain relief was observed (day following injection) and sustained for 84 days at the lowest dose tested. Pain during walking, assessed with a 10-point scale called WOMAC, declined by 4.7 points compared to placebo.</li><li>No dose-limiting toxicities or safety signals were observed.</li><li>Pivotal studies should launch later this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3424603\" data-linked=\"Sorrento up 7% premarket on positive resiniferatoxin data\" data-tweet=\"$SRNE - Sorrento up 7% premarket on positive resiniferatoxin data https://seekingalpha.com/news/3424603-sorrento-up-7-premarket-on-positive-resiniferatoxin-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3424603-sorrento-up-7-premarket-on-positive-resiniferatoxin-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424600\" data-ts=\"1548164697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGP\" target=\"_blank\">MGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424600-mgm-growthminus-4_0-after-500m-notes-offering-proposed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM Growth -4.0% after $500M notes offering proposed</a></h4><ul><li>MGM Growth Properties Operating Partnership and MGP Finance Co-Issuer subsidiaries of MGM Growth Properties (NYSE:<a href='https://seekingalpha.com/symbol/MGP' title='MGM Growth Properties LLC'>MGP</a>) <a href=\"https://seekingalpha.com/pr/17386589-mgm-growth-properties-operating-partnership-lp-announces-proposed-private-offering\" target=\"_blank\">propose to offer</a> $500M of senior notes due 2027 in a private offering.</li><li>MGP <font color=\"red\">-4.0%</font> in premarket trading.</li><li>Issuers plan to use proceeds to repay revolver draws that were primarily related to acquisitions completed in 2018 or expected to be closed in early 2019 and to pay fees and expenses related to the offering.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3418499-mgm-resorts-mgm-growth-pact-park-mgm-nomad-las-vegas\" target=\"_blank\">MGM Resorts, MGM Growth in pact on Park MGM, NoMad Las Vegas</a> (Dec. 20, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3424600\" data-linked=\"MGM Growth -4.0% after $500M notes offering proposed\" data-tweet=\"$MGP - MGM Growth -4.0% after $500M notes offering proposed https://seekingalpha.com/news/3424600-mgm-growthminus-4_0-after-500m-notes-offering-proposed?source=tweet\" data-url=\"https://seekingalpha.com/news/3424600-mgm-growthminus-4_0-after-500m-notes-offering-proposed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424598\" data-ts=\"1548164614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424598-tg-therapeutics-up-11-on-receiving-breakthrough-therapy-designation-for-umbralisib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics up 11% on receiving Breakthrough Therapy Designation for umbralisib</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17386574-tg-therapeutics-receives-breakthrough-therapy-designation-u-s-food-drug-administration\" target=\"_blank\">grants</a> TG Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a>) umbralisib (TGR-1202) Breakthrough Therapy Designation for the treatment of adult patients with marginal zone lymphoma &#40;MZL&#41; who have received at least one prior anti-CD20 regimen.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application.</li><li>Top-line results from the MZL single agent umbralisib cohort of the UNITY-NHL study is expected by mid-year.</li><li>Shares are up <font color=\"green\">11%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3424598\" data-linked=\"TG Therapeutics up 11% on receiving Breakthrough Therapy Designation for umbralisib\" data-tweet=\"$TGTX - TG Therapeutics up 11% on receiving Breakthrough Therapy Designation for umbralisib https://seekingalpha.com/news/3424598-tg-therapeutics-up-11-on-receiving-breakthrough-therapy-designation-for-umbralisib?source=tweet\" data-url=\"https://seekingalpha.com/news/3424598-tg-therapeutics-up-11-on-receiving-breakthrough-therapy-designation-for-umbralisib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3424597\" data-ts=\"1548164509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMWYY\" target=\"_blank\">BMWYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3424597-german-automakers-caught-in-trade-battle-crosshairs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">German automakers caught in trade battle crosshairs</a></h4><ul> <li>BMW (<a href='https://seekingalpha.com/symbol/BMWYY' title='Bayerische Motoren Werke AG ADR'>OTCPK:BMWYY</a>), Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) and Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>) could become \"collateral damage\" in the Trump Administration's fight to <a href=\"https://www.wsj.com/articles/auto-investors-should-buckle-up-for-tariff-threats-11548161074\" target=\"_blank\">gain</a> broader access to European food markets, according to The Wall Street Journal's Stephen Wilmot.</li> <li>Trump is seen as having a political need to give farmers a lift due to the hit some are taking from lost exports to China. He has until next month to decide if a 25% tariff will be imposed on imported cars to pressure the EU on the issue.</li> <li>Wilmot warns that auto investors could be in for a bumpy ride amid the trade battle swings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3424597\" data-linked=\"German automakers caught in trade battle crosshairs\" data-tweet=\"$BMWYY $BMWYY $DDAIF - German automakers caught in trade battle crosshairs https://seekingalpha.com/news/3424597-german-automakers-caught-in-trade-battle-crosshairs?source=tweet\" data-url=\"https://seekingalpha.com/news/3424597-german-automakers-caught-in-trade-battle-crosshairs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}